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A B S T R A C T
Background
Over the last 10 years laparoscopy and minilaparotomy have become increasingly common approaches for the surgical removal of
benign ovarian tumours. However, in the event that a tumour is found to be malignant, laparotomy is the appropriate procedure.
Careful preoperative assessment including transvaginal ultrasound with morphological scoring, colour doppler assessment of vascular
quality, and serum cancer antigen 125 (CA 125) level is desirable.
Objectives
To determine the benefits, harms, and cost of laparoscopy or minilaparotomy compared with laparotomy in women with benign ovarian
tumours.
Search methods
We searched electronic databases, trial registers, and reference lists of published trial reports. Reference lists from trials and review
articles were searched.
Selection criteria
All randomised controlled trials comparing either laparoscopy or minilaparotomy with laparotomy for benign ovarian tumours.
Data collection and analysis
Eight review authors independently assessed the eligibility and quality of each study and extracted the data.
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Main results
The results of nine randomised controlled trials (N = 482 women) showed that laparoscopic surgery was associated with fewer adverse
events of surgery (surgical injury or postoperative complications including fever or infection) (OR 0.3, 95% CI 0.2 to 0.5), less
postoperative pain (VAS score WMD -2.4, 95% CI -2.7 to -2.0), greater likelihood of being pain free after two days (OR 7.42, 95%
CI 4.86 to 11.33), and fewer days in hospital (WMD -2.88, 95% CI -3.1 to -2.7) than with laparotomy.
In one study that reported costs, laparoscopy was associated with a significant reduction in costs compared to laparotomy (WMD -
USD 1045, 95% CI -1348 to -742) in 1993. Very high levels of heterogeneity made it inappropriate to pool data on duration of
surgery.
Three RCTs compared laparoscopy versus minilaparotomy and found that laparoscopy was associated with reduced odds of any adverse
event (surgical injury or postoperative complications) (OR 0.10, 95% CI 0 to 0.8) and lower VAS scores for pain (WMD -1.0, 95%
CI -1.6 to -0.45). Duration of hospital stay ranged between 1 and 2.2 days, with substantial heterogeneity.
Authors’ conclusions
In women undergoing surgery for benign ovarian tumours, laparoscopy was associated with a reduction in fever, urinary tract infection,
postoperative complications, postoperative pain, number of days in hospital, and total cost. These findings should be interpreted with
caution since only a small number of studies were identified. These included a total of only 769 women and not all of the important
outcomes were reported in each study.
P L A I N L A N G U A G E S U M M A R Y
Laparoscopic surgery for benign ovarian tumours is associated with less pain, shorter hospital stay, and fewer adverse events
than with laparotomy
Laparoscopy is a modern surgical technique in which operations are performed through small incisions (usually 2 to 3 cm long) using
a laparoscope. This is a telescopic rod lens system that is usually connected to a video camera. In the 12 controlled studies identified,
laparoscopic surgery was associated with reduced risk of any adverse events from surgery, less pain, and fewer days in the hospital when
compared to laparotomy, the traditional surgical technique.There was no difference between the procedures with regard to outcomes
of fever, postoperative infections, and tumour recurrence.
B A C K G R O U N D
The ovary is a complex embryological, histological, and physio-
logical structure that is capable of developing over 50 types of pri-
mary neoplasm variants, from benign to borderline and malignant
tumours (Barber 1984). Functional and benign ovarian cysts are
the most frequent abnormal gynaecological structural findings in
women of reproductive age, and are among the five main causes of
hospitalisation for gynaecological disease in the United States and
England (Westhoff 1992). Data from the National Hospital Dis-
charge Survey, from 1988 to 1990, showed that the average annual
rates of hospitalisation for benign ovarian cysts was 32.7 (95% CI
28.8 to 36.6) per 10,000 women of reproductive age; 68% of these
patients were submitted to a surgical procedure (Velebil 1995).
Approximately 80% of ovarian tumours can be successfully treated
surgically using an endoscopic technique (Canis 1994). Many ad-
vantages of laparoscopic gynaecologic surgery have clearly been
demonstrated including shorter length of hospital stay, decreased
postoperative pain and recovery time, and less adhesion formation
(Canis 1994; Lundorff 1991).
Malignant ovarian neoplasms are responsible for 4% of all malig-
nant tumours affecting women. They are the second most com-
mon cause of death from gynaecological cancer and the fourth
most common cause of death from all types of cancer affecting
women (Ekerhovd 2001). The incidence of ovarian tumours pro-
gressively increases with age, with 3.2 cases per 100,000 women
between the ages of 15 to 39 years and 54 cases per 100,000
women above the age of 70 years (Yancik 1993). The ovary is
involved for approximately half of all women with endometriosis
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(Jenkins 1986). However, a malignant ovarian tumour has been
documented to arise clinically in 0.3% to 0.8% of patients with
ovarian endometriosis (Heaps 1990; Hitti 1990). Dermoid cysts
are the most prevalent germ cell tumour and account for up to
25% of ovarian neoplasms in premenopausal women. Malignancy
occurs in less than 3% and is most frequent in postmenopausal
women (Chistopherson 1989; Woodruff 1968). Benign, border-
line, and malignant lesions have been identified in the same sur-
gical specimen. The frequency and speed of the evolution from
dysplasia into cancer remains unknown (Scully 2000).
When an ovarian tumour is detected, it is necessary to establish
whether it is likely to be malignant or benign as this diagnosis will
guide decision making on the surgical approach. This cannot be
determined with 100% accuracy until inspection of the abdom-
inal cavity, cytological examination of the peritoneal liquid, and
histological examination of the surgical specimens (Canis 1994).
However, a number of criteria can facilitate preoperative diagno-
sis. These are as follows.
(1) Transvaginal ultrasonography with the use of a morphological
scoring system (internal borders, septations, papillary projections,
tissue echogenicity and volume) (Sassone 1991). An ovarian vol-
ume of above 20 cm3 in the reproductive age group and above 10
cm3 in the postmenopausal group may indicate a need for further
investigation (Van Nagell 2000).
(2) Colour Doppler ultrasonography (US) allows vascular quality
to be assessed from the vascular resistance index (RI) and the pul-
satility index (PI), with cut-off values for malignancy less than 0.4
and 1, respectively (Brown 1994). However for ovarian masses it
is still not known if benign and malignant lesions can be differen-
tiated with the use of colour and pulsed Doppler US.
(3) CA 125 may be detected in the serum of up to 86% of patients
with ovarian neoplasms, with levels of 35 U/ml or higher being
considered suspicious (Chou 1994; Maggino 1987).
In a study of 191 women with ovarian tumours (Timmerman
1999), logistic regression was used to develop an algorithm to pre-
operatively distinguish between benign and malignant ovarian tu-
mours. The most useful variables in the logistic regression analysis
were menopausal status, serum CA 125 level, the presence of one
or more papillary growth(s) of greater than 3 mm, and a colour
score indicative of tumour vascularity and blood flow. The opti-
mised algorithm had a sensitivity of 95.9% and a specificity of
87.1% in the group studied. A subsequent publication attempting
to validate this model and others using a large heterogeneous data
set found few models to be robust and generalisable, perhaps due
to the subjective nature of some of the component assessments
(Van Holsbeke 2007). It is generally accepted that ovarian malig-
nancy can seldom be absolutely excluded prior to surgery.
McDowell reported the first successful removal of an ovarian tu-
mour in 1817 (McDowell 1817). The laparotomy approach was
the only option until the end of the 20th century. The first surgical
laparoscopic procedure was performed by Semm and Mettler in
1980 (Semm 1980). This approach was thought to be associated
with less surgical trauma and lower hospital costs (Canis 2000;
Kehlet 1999; Lorenz 1999; Maiman 1991). Approximately 80%
of ovarian tumours can be successfully resected using a laparo-
scopic (endoscopic) technique (Canis 2000). The potential advan-
tages of this approach include: improved magnification that makes
the diagnosis of peritoneal metastases more certain; the avoidance
of an inappropriate transverse laparotomy incision in cases with
a malignant tumour; and, most important, the prevention of un-
necessary laparotomies in patients with benign ovarian tumours
(Canis 2000). The laparoscopic approach is used in patients whose
adnexal mass is less than 10 cm in diameter, whatever the ultra-
sonographic appearance. Masses of more than 8 cm are managed
more cautiously and evaluated by laparoscopy when unilocular
or bilocular, or when calcifications are identified) (Canis 1994a;
Wong 2000). An alternative minimally invasive procedure for the
management of ovarian cysts is minilaparotomy (using a 3 to 7
cm transverse skin incision, 2 to 4 cm above the pubic symphysis)
(Panici 2007). For dermoid cysts and endometriomata, special at-
tention is necessary during the procedure to avoid spillage and
subsequent chemical peritonitis with increased risk of subsequent
postoperative adhesions. In the case of dermoid cysts, there is a
risk of granulomatous reactions (Nissole 1994).
Postoperative adhesions are sequelae from ovarian surgery and may
result in mechanical infertility in women of reproductive age (
Bassil 1994). Laparoscopic ovarian cystectomy is associated with
decreased postoperative adhesion formation when compared with
laparotomy (Lundorff 1991).
Some endoscopic procedures are performed using carbon dioxide
(CO2) techniques. This is considered by some authors to increase
the risk of activating cell enzymes, which may lead to mitosis and
an increase in the production of tumour growth factor as has been
shown in an animal model (Greene 1995). An increasing rate of
trocar-site recurrences and intra-abdominal growth of metastases
has been reported after laparoscopic surgery in patients with ma-
lignant intra-abdominal tumours (Martinez 1995). For this rea-
son, if a tumour turns out to be malignant during laparoscopy, the
procedure should immediately be converted to a laparotomy. In
these cases, if laparotomy is delayed for more than eight days, pro-
gression from stage Ic to stage II may occur (Kindermann 1995).
If a tumour turns out to be malignant during laparoscopy and
inadvertent rupture occurs, the procedure should be converted to
a laparotomy with a longitudinal medial incision to allow the ap-
propriate, necessary surgical staging and debulking procedures.
As it is not yet established whether laparoscopy, laparotomy or
minilaparotomy is the best approach for ovarian tumours assumed
to be benign, we have performed a systematic review of all ran-
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domised controlled trials in which laparoscopy and laparotomy
or minilaparotomy were compared for the treatment of benign
ovarian tumours.
O B J E C T I V E S
To determine the benefits, harms, and costs of laparoscopic surgery
compared with laparotomy or minilaparotomy in women with
ovarian tumours assumed to be benign.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) which compared laparo-
scopic surgery with laparotomy or minilaparotomy as a treatment
for ovarian tumours assumed to be benign.
Types of participants
Inclusion criteria
We considered three groups of women with benign ovarian tu-
mours who were treated surgically by either laparoscopy, mini-
laparotomy, or laparotomy: those with any type of benign ovar-
ian tumour; those with dermoid cysts; and those with endometri-
omata. We only included trials where women were investigated in
the preoperative setting with transvaginal or transabdominal ul-
trasonography, or both, for analysis of the morphological scoring
(internal borders, septations, papillary projections, echogenicity,
and volume) in order to exclude from the trial women with tu-
mours that were likely to be malignant.
We noted whether trials reported:
(1) the use of colour Doppler transvaginal ultrasonography to
assess vascular quality from the vascular resistance index (RI) and
pulsatility index (PI);
(2) preoperative estimation of serum CA 125 levels, levels greater
than 35 U/ml were suggestive of malignancy.
Exclusion criteria
(1) Women with ovarian tumours having features suggestive of
malignancy, determined during preoperative assessment.
(2) Women with gynaecological cancer.
(3) Trials where the author did not describe the preoperative as-
sessment that was performed.
Types of interventions
Two surgical approaches used for the management of ovarian tu-
mours assumed to be benign were compared: laparoscopy and la-
parotomy. Laparotomy was further defined as either ’standard la-
parotomy’ with a Pfannansteil incision or ’minilaparotomy’, where
the transverse incision was 3 to 7 cm long.
Whenever possible, the results were analysed by type of surgeon:
gynaecological versus general surgeon.
Types of outcome measures
The major outcome measures were as follows.
1 Surgical
• Mean duration of surgery
• Change of diagnosis from benign to malignant tumour
2 Adverse events











• Urinary tract infection
• Thromboembolism
• Perioperative mortality




5 Any other adverse events of surgery (either surgical injury, postop-
erative complications, or other adverse events of surgery)
6 Short-term outcomes
• Pain: VAS scores
• Pain: pain free at 24 to 48 hrs postoperation
• Pain: requirement for analgesia
• Length of hospital stay
• Recurrence rate after 6 to 12 months
• Blood loss determined by haemoglobin level
7 Economic measure
• Direct cost of surgical procedures
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Search methods for identification of studies
For the update of this review in 2007, we searched the
Cochrane Menstrual Disorders and Subfertility Group Trials
Register (November 2007), Cochrane Central Register of Con-
trolled Trial (CENTRAL) (The Cochrane Library), MEDLINE
(1966 to November 2007), EMBASE (1985 to November 2007),
CINAHL (1984 to November 2007), SciSearch (1991 to Novem-
ber 2007), and LILACS (1982 to November 2007). See Appendix
1; Appendix 2; Appendix 3; Appendix 4 for the search strategies.
The citation lists of relevant publications and included studies,
and abstracts of scientific meetings were checked through hand-
searching for further trials; experts in the field were contacted to
identify further reports of trials.
A prospective handsearch of publications (1980 to 2007) on the
surgical treatment for benign ovarian tumours was carried out in
the following journals: American Journal of Obstetrics and Gyne-
cology; British Journal of Obstetrics and Gynaecology; Gyneco-
logic Oncology; Obstetrics and Gynecology; International Journal
of Gynecological Cancer; Gynaecological Endoscopy; The Jour-
nal of the American Association of Gynecologic Laparoscopists;
European Journal of Obstetrics, Gynecology, and Reproductive
Biology; Journal of Reproduction Medicine; Gynecologie et Ob-
stetrique; Fertility and Sterility; Human Reproduction; and Jour-
nal of Gynecologic Surgery. Abstracts presented to the following
international societies were handsearched: British Society for Gy-
naecological Endoscopy, European Society for Gynaecological En-
doscopy, International Society for Gynecologic Endoscopy, Aus-
tralian Gynaecological Endoscopy Society, Hong Kong Gynae-
cological Endoscopy Society, Italian Society for Gynaecological
Endoscopy; and American Association of Gynecologic Laparo-
scopists.
Data collection and analysis
Selection of studies
Studies were assessed according to the inclusion criteria above.
Four review authors (LRM, JF, MIR, DDR) worked in pairs; agree-
ment on eligibility was reached. A standard checklist was used to
guide this process. No effort was made to blind the names of au-
thors, institutions, or journals. The reason for this was that the
review authors were very familiar with the literature on surgical
treatment for benign ovarian tumours and would have recognised
most studies even if they were blinded. For this update, two re-
view authors (MCB and ATS) independently assessed citations for
inclusion. Any discrepancies were resolved by a co-author (RG or
SF). When eligibility could not be determined from the published
study the authors were contacted for clarification. There were no
language restrictions.
Methodological quality and data extraction
Included trials were analysed for the following specific criteria and
methodological details. Using a standard checklist to guide this
process, the review authors collected information on study design
for each trial. Differences in data extraction were resolved by con-
sensus, referring back to the original article. When trials were re-
ported in more than one publication, data were extracted from the
most recent article, referring to other articles for methodological
details, baseline characteristics, or further outcomes when appro-
priate.
Data extraction
Data regarding details on the study population, intervention, and
outcomes were extracted by one review author (LRM, DDR,
or MIR) and checked independently by the other three authors
(MCB, JF, ATB ) using a data extraction form. This included the
following information.
Trial characteristics
(1) Method of randomisation
(2) Presence or absence of blinding to treatment allocation
(3) Quality of allocation concealment
(4) Number of patients randomised, excluded, or lost to follow
up
(5) Whether an intention-to -treat analysis was performed
(6) Whether a power calculation was done
(7) Duration, timing, and location of the study
Characteristics of the women participants
(1) Age and any other baseline characteristics of women in the
study
(2) Method used to define ovarian cysts in the laparoscopy surgery
(3) Details of the preoperative assessment
(4) Other inclusion criteria
(5) Exclusion criteria
(6) Histological type of ovarian tumour (endometrioma, dermoid
cyst, or other)
Interventions used
(1) Laparoscopy: ovarian cystectomy (unilateral and bilateral) or
oophorectomy (unilateral and bilateral), number of ports, type of
anaesthesia, and histological types (endometriosis, dermoid cysts,
and others).
(2) Laparotomy: ovarian cystectomy (unilateral and bilateral) or
oophorectomy (unilateral and bilateral), type and length of inci-
sion.
(3) Minilaparotomy: where the transverse incision was 3 to 7
cm, ovarian cystectomy (unilateral and bilateral) or oophorectomy
(unilateral and bilateral).
Outcomes
The major outcome measures were:
(1) surgical duration;
(2) adverse events - surgical injury;
(3) postoperative complications;
(4) any other adverse events;
(5) any adverse events from surgery (either surgical injury, post-
operative complications, or other adverse events);
(6) short-term outcomes;
(7) economic measure.
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Assessment of methodological quality of included studies
All assessments of the quality of trials and data extraction were per-
formed independently by five review authors (LRM, DDR, MIR,
MCB, ATS) using forms designed by The Cochrane Collabora-
tion. The quality of allocation concealment was assigned for each
trial using the following criteria:
• Grade A: adequate concealment;
• Grade B: uncertain concealment;
• Grade C: clearly inadequate concealment.
Trials with quasi-randomisation designs were excluded.
Attrition bias (loss of participants)
We described completeness of follow up for each trial and included
reasons for loss of participants, for example withdrawals, dropouts,
and protocol deviations, when reported.
Performance bias (blinding of participants, researchers, and
outcome assessors)
Blinding of participants, caregivers, and outcome assessors was
assessed and described or reported as ’not stated’.
Analysis
Statistical analysis was performed in accordance with the guidelines
for statistical analysis developed by the Menstrual Disorders and
Subfertility Group. All trials were initially included in the analysis.
Subgroup analysis was performed by looking separately at dermoid
cysts and endometriomata ovarian cysts.
For categorical outcomes (surgical injuries, change of diagnosis
from benign to malignant tumour, postoperative complications,
any adverse events of surgery, pain free at 24 to 48 hours, readmis-
sion rates) we extracted the numbers reported for each outcome
for each group of women. Results for each study were expressed
as odds ratios (OR) with 95% confidence intervals (CI) and com-
bined for meta-analysis with the RevMan software using the Peto-
modified Mantel-Haenszel method.
Statistical heterogeneity among the results of different studies was
examined by inspecting both the scatter points in the graphs and
the overlap in their confidence intervals and, more formally, by
checking the results of Chi2 tests. Because there were few studies,
a P-value for the Chi2 tests of less than 0.10 was used to indicate
heterogeneity. The outcomes were pooled statistically when no
clinical heterogeneity was apparent. However, since clinical and
methodological diversity occur in a meta-analysis, statistical het-
erogeneity is inevitable. An alternative approach that quantifies the
effect of heterogeneity is the I2 statistic, providing a measure of the
degree of inconsistency in the results of the studies with 95% un-
certainty intervals (Higgins 2003). This describes the percentage
of the variability in the effect estimates that is due to heterogeneity
rather than sampling error (chance). A value of 0% indicates no
observed heterogeneity and a value greater than 50% may be con-
sidered as substantial heterogeneity. When it is inappropriate to
pool the data due to clinical or statistic heterogeneity a systematic
review without meta-analysis is performed.
For continuous outcomes (duration of surgery, length of hospital
stay, and direct costs of surgical procedures) we used means and
standard deviations to derive a weighted mean difference (WMD)
with 95% confidence intervals (CI) using the RevMan software.
Difficulties were found with the reporting of continuous outcomes
(for example duration of surgery), where the data were skewed
and the authors correctly presented them as medians with a range.
Whenever possible, original data were obtained from the authors
although post-treatment means and standard deviations were not
always available or calculable. Where only medians and ranges
were available, the median was regarded as being identical to the
mean and a crude estimate of the standard deviation (SD) was
calculated from the range ((range X 0.95)/4). This method is not
ideal for skewed data and was likely to result in an over-estima-
tion of the SD. Therefore, a sensitivity analysis (planned a priori)
was performed with inclusion and exclusion of trials with skewed
data in the meta-analysis. The distribution of data on duration of
surgery is highly likely to be skewed and in these cases the ideal and
most appropriate statistical analysis was probably nonparametric
rather than inclusion in a meta-analysis assessing a WMD. Where
a SD is not reported it can be calculated from either the standard
error (SE) or the 95% CIs. A SD can be obtained from the SE
of the mean by multiplying with the square-root of the sample
size: SD= SEx
√
N. When making this transformation, SEs must
be of means calculated from within an intervention group and not
SEs of the difference in means computed between intervention
groups.
CIs for means can also be used to calculate SDs. Again, the follow-
ing applies to CIs for mean values calculated within an interven-
tion group and not for estimates of differences between interven-
tions. Most CIs are 95% CIs. If the sample size is large (say bigger
than 100 in each group), the 95% CI is 3.92 SEs wide (3.92 = 2 ×
1.96). The SD for each group is obtained by dividing the length
of the CI by 3.92 and then multiplying by the square root of the
sample size: SD =
√
N x (upper limit-lower limit)/3.92 (section
7.7.3.2) (Higgins 2008).
We pooled the effect measure within a random-effects model be-
cause the outcomes were heavily influenced by the context of care.
Sensitivity analysis was planned a priori to compare the study re-
sults for type of intervention (ovarian cystectomy or oophorec-
tomy), histological types (any type of benign ovarian tumour, der-
moid cysts, and ovarian endometriomata), and study design and
reporting (adequate versus unclear allocation concealment). Both
fixed and random-effects model meta-analyses were undertaken to
assess the robustness of the results.
R E S U L T S
Description of studies
Initially 32 studies were identified which compared laparoscopy
and laparotomy for benign ovarian tumours (Figure 1). Twenty
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of these studies were excluded because they were not randomised
(Albini 1994; Bateman 1994; Bulletti 1996; Chapron 1997;
Darwisch 2001; Deckardt 1994; Hidlebaugh 1994; Hidlebaugh
1997; Howard 1995; Laberge 2006;Lin 1995; Marana 2004;
Mettler 2001a; Papasakelariou 1995; Paredes 1997; Pittaway
1994; Quinlan 1997; Thomas 2006; Yuen 1995; Zanetta 1999).
See the ’Characteristics of excluded studies’ table.
Twelve randomised controlled trials that were published between
1995 and 2007 met the inclusion criteria for this review (Badawy
2002; Buchweitz 2005; Damiani 1998; Fanfani 2004; Mais 1995;
Mais 1996; Mais 2003; Morgante 1998; Nitke 1996; Panici 2007;
Panici 2007a; Yuen 1997) (Figure 1).
The six additional primary studies in this update were RCTs (




Ten studies were of single-centre design and two trials were con-
ducted in two centres. Eight included trials were conducted in
Italy (Damiani 1998; Fanfani 2004; Mais 1995; Mais 1996; Mais
2003; Morgante 1998; Panici 2007; Panici 2007a). The other four
studies were from Israel (Nitke 1996), Hongkong (Yuen 1997),
Germany (Buchweitz 2005), and Egypt (Badawy 2002).
2. Designs
Nine studies were randomised comparisons of laparoscopy ver-
sus laparotomy for benign ovarian tumours (Badawy 2002;
Buchweitz 2005; Damiani 1998; Mais 1995; Mais 1996; Mais
2003; Morgante 1998; Nitke 1996; Yuen 1997). Two studies com-
pared laparoscopy with minilaparotomy (Fanfani 2004; Panici
2007a), and a further study compared laparoscopy with laparo-
scopic guided minilaparotomy Panici 2007).
3. Participants
All women included in the trials had ovarian tumours and un-
derwent a preliminary workup including transvaginal or transab-
dominal ultrasonography, or both. In all trials, the type of sur-
geon (gynaecologists or general surgeons) was not defined. Only
one trial reported that surgeons were undergoing training un-
der supervision of an experienced surgeon (Yuen 1997). Eight
studies mentioned that all surgical procedures were performed by
the same investigators (Badawy 2002; Buchweitz 2005; Damiani
1998; Fanfani 2004, Mais 1995, Mais 1996, Mais 2003; Panici
2007). Six studies recorded the body mass index of the patients
(Badawy 2002; Buchweitz 2005; Fanfani 2004; Mais 1995; Panici
2007; Panici 2007a ). Eight studies included women with all
histopathological types of benign ovarian tumours (Badawy 2002;
Buchweitz 2005; Damiani 1998; Fanfani 2004; Mais 1995; Panici
2007; Panici 2007a; Yuen 1997). Three studies defined a subgroup
with dermoid cysts (Morgante 1998; Nitke 1996; Mais 2003).
Only one randomised trial considered a subgroup of patients with
endometriomata ovarian cysts (Mais 1996).
4. Interventions
Ovarian cystectomy was performed by laparoscopy or laparotomy
in 100% of the cases in five studies (Damiani 1998; Mais 1995;
Mais 1996; Morgante 1998; Nitke 1996). Ovarian cystectomy
was reported as bilateral in around 20% of cases in two trials, ei-
ther by laparoscopy or laparotomy (Morgante 1998; Nitke 1996).
Oophorectomy was performed by laparoscopy or laparotomy in
around 30% of the cases (Yuen 1997) in each group and 100% of
the cases in one trial (Buchweitz 2005). Ovarian cystectomy was
reported in 87% of cases in the laparoscopy group and 70% of
laparotomies (Badawy 2002).
In five studies there were no co-interventions in either group (la-
paroscopy and laparotomy) (Damiani 1998; Mais 1995; Mais
1996; Morgante 1998; Yuen 1997); in one trial concomitant pro-
cedures were performed (Nitke 1996).
No trials compared a surgical approach performed by one surgeon
with another surgical approach performed by a second surgeon.
Seven trials (Damiani 1998; Fanfani 2004; Mais 1995; Mais 1996;
Mais 2003; Panici 2007) reported that a team that was experienced
in laparoscopic surgery performed the procedures. Frozen section
was referred to in three trials (Buchweitz 2005; Fanfani 2004;
Panici 2007).
5. Outcomes
For each outcome we considered three groups, according to the
ovarian tumour histopathology: all histological types of benign
ovarian tumour, dermoid ovarian cysts, and ovarian endometri-
omata. The four major outcome measures were as follows.
(1) Surgical
• The mean duration of surgery was reported by 10 studies
(Badawy 2002; Buchweitz 2005; Damiani 1998; Fanfani 2004;
Mais 1995; Mais 1996; Mais 2003; Morgante 1998; Nitke 1996;
Yuen 1997). Both studies by Panici reported median operating
time together with the interquartile range (Panici 2007; Panici
2007a).
(2) Adverse effects of surgery
• Surgical injury, postoperative complications, and any other
adverse events of surgery were described in most studies but four
studies stated that no postoperative complications occurred
(Mais 1995; Mais 1995; Mais 2003; Nitke 1996); described in
all twelve studies.
• In our update three trials described incidence of a suspected
malignant ovarian tumour during the procedure by frozen
section analysis (Buchweitz 2005; Fanfani 2004; Panici 2007).
(3) Short-term recovery
• Pain (VAS scores) was reported in four studies (Mais 1995;
Morgante 1998; Panici 2007a; Yuen 1997)
• Pain free at 24 to 48 hours after surgery was reported in six
studies (Badawy 2002; Mais 1995; Mais 2003; Morgante 1998;
Panici 2007a; Yuen 1997)
• Requirement for analgesia was reported in four studies
(Badawy 2002; Buchweitz 2005; Fanfani 2004, Yuen 1997)
• Mean length of hospital stay was reported in nine studies,
median length of stay with the interquartile range was reported
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in two studies (Panici 2007; Panici 2007a), and Mais 2003
described numbers discharged within three days of surgery
• Recurrence rates at 6 to 12 months were reported in four
studies (Damiani 1998; Mais 1995; Mais 1996; Mais 2003)
• Blood loss measured by decrease in mean haemoglobin level
was described by Buchweitz 2005, and Panici 2007 reported the
median pre and postoperative haemoglobin levels in each group
together with the 25 to 75 percentile range.
(4) Economic measure
• Direct costs of surgical procedures were described in only
one study from Italy (Damiani 1998).
Risk of bias in included studies
See Figure 1; Figure 2. Seven trials were given a score of A based on
adequate concealment prior to randomisation; used in conjunc-
tion with numbered sealed envelopes where the seal was broken
in the anaesthetic room prior to surgery (Badawy 2002; Fanfani
2004; Mais 1995; Mais 1996; Mais 2003; Panici 2007; Yuen
1995). The remaining five trials received an allocation score B
since the method of randomisation was not reported in the publi-
cation (Buchweitz 2005; Damiani 1998; Morgante 1998; Panici
2007a) (Table 1).
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Five trials showed a power calculation for the sample size
(Buchweitz 2005; Fanfani 2004; Mais 1995; Mais 1996; Yuen
1997) and only one trial stated that it performed an intention-
to-treat analysis (Panici 2007a). One study (Badawy 2002) did
not mention randomisation but personal communication with Dr
Badawy resulted in confirmation that participants were in fact ran-
domly allocated to treatment groups by the principal investigator,
using computerised random tables at the time of admission of the
patients to the hospital. Numbers of women included in the trials
were generally small, ranging from 10 to 64 per treatment arm.
Two studies reported no loss from follow up six months after
surgery (Mais 1995; Mais 1996) and another study reported no
losses after two weeks follow up (Morgante 1998). In Nitke 1996,
follow up was only until discharge from hospital after the surgery
(maximum 4.3 days) and no losses were reported. Damiani and
Badawy conducted a follow-up assessment at 12 months after
surgery but did not mention any patient losses to follow up
(Badawy 2002; Damiani 1998). One study (Yuen 1997) stated
that four of the original 110 patients recruited into the study re-
fused randomisation and another four were lost to follow up with
the result that a total of eight of the original 110 patients recruited
(7.3%) were not assessed at the end of follow up, six weeks after
surgery. Mais reported five years of follow up (Mais 2003); Panici
2007 stated that follow up was for three months; and three studies
did not specifically state the duration of follow up but it was likely
to have been less than three months (Buchweitz 2005; Fanfani
2004; Panici 2007a).
Inter-rater agreement for quality assessment by individual review
authors was good (Cohen‘s kappa = 0.79). Disagreements were
resolved through discussion in all cases (MCB, ATS, JF).
Sensitivity analysis by including and excluding the studies of lower
quality assessment was performed based on the quality of alloca-
tion concealment (A, B, C).
Effects of interventions
Included studies
Twelve studies and 769 patients were included in this review.
Nine studies compared laparoscopy and laparotomy (Badawy
2002; Buchweitz 2005; Damiani 1998; Mais 1995; Mais 1996;
Mais 2003; Morgante 1998; Nitke 1996; Yuen 1997). Three stud-
ies compared laparoscopy and minilaparotomy (Fanfani 2004;
Panici 2007; Panici 2007a).
1 Laparoscopy versus laparotomy
1.1 Surgical outcomes
(a) Duration of surgery
(i) In the studies of any type of benign ovarian tumour (Badawy
2002; Buchweitz 2005; Damiani 1998; Mais 1995; Yuen 1997)
there was considerable heterogeneity in the estimates and it was
inappropriate to pool the data (Figure 3).
Figure 3. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.1 Surgery - Duration of
surgery (min).
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(ii) In the subgroup of dermoid cysts (Mais 2003; Morgante
1998; Nitke 1996) there was substantial inconsistency making it
inappropriate to pool the data (Chi2 = 7.67, P = 0.02, I2 = 74%)
(Figure 2).
(iii) In the subgroup of ovarian endometriomata (Mais 1996)
there were no statistically significant differences between treat-
ments arms for duration of surgery (Figure 2).
(b) Diagnosis of malignant tumour
In one study, the ovarian tumours in four women were found
to be malignant after frozen section was performed during la-
paroscopy, with subsequent conversion to laparotomy (Buchweitz
2005). Badawy 2002 excluded from the analysis one patient in the
laparoscopy group who had significant intracystic lesions which
were identified during endocystic evaluation. Biopsy later showed
serous cystadenoma with proliferation activity of the epithelial
cells and nuclear abnormalities but with no infiltrative destructive
growth (low malignant potential) (Badawy 2002) (Figure 4).
Figure 4. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.2 Surgery - Change of
diagnosis to malignant tumour.
1.2 Adverse events
(a) Surgical injury
Nine studies provided data for analysis of surgical injuries (Badawy
2002; Buchweitz 2005; Damiani 1998; Mais 1995; Mais 1996;
Mais 2003; Morgante 1998; Nitke 1996; Yuen 1997).
(i) In the subgroup of any type of benign ovarian tumour (Badawy
2002; Buchweitz 2005; Damiani 1998; Mais 1995; Yuen 1997)
no injuries to the ureter, small bowel, or colon were reported. One
study (Yuen 1997) reported a single case of bladder injury in the
laparotomy group and two studies (Badawy 2002; Yuen 1997)
each reported a single case of vascular injury in the laparoscopy
group.
(ii) In the subgroup of dermoid cysts (Morgante 1998; Nitke 1996)
no surgical injuries were reported.
(iii) In the subgroup of ovarian endometriomata (Mais 1996) no
surgical injuries were reported.
(b) Postoperative complications
Postoperative complications were infrequent in all of the included
studies. Haematoma, chemical peritonitis, requirement for blood
transfusion, and perioperative mortality were not reported in any
of the nine included studies. However, febrile morbidity, incision
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infection, urinary tract infection, urinary retention, thromboem-
bolism, and intestinal obstruction were reported as uncommon
postoperative complications.
(i) In the subgroup of any type of benign ovarian tumour in four
studies there was a decreased risk of fever in the laparoscopy group
(Peto OR 0.37, 95% CI 0.18 to 0.76) without heterogeneity and
with I2 = 0% (Buchweitz 2005; Damiani 1998; Mais 1995; Yuen
1997) (Figure 5).
Figure 5. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.10 Post operative
complications - Febrile morbidity.
There was a non-statistically significant difference between la-
paroscopy and laparotomy regarding the risk of incision infection
(Peto OR 0.18, 95% CI 0.05 to 0.67) and urinary tract infection
(Peto OR 0.3, 95% CI 0.08 to 1.16) (Badawy 2002; Yuen 1997)
(Figure 6; Figure 7).
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Figure 6. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.11 Post operative
complications - Incision infection.
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Figure 7. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.12 Post operative
complications - Urinary tract infection.
There was also a decreased risk of urinary retention in the la-
paroscopy group (Peto OR 0.12, 95% CI 0.02 to 0.89) in the one
trial that reported this outcome (Yuen 1997) (Figure 8) and blood
loss measured by haemoglobin levels (WMD -0.6, 95% CI -1.39
to 0.19) (Buchweitz 2005) (Figure 9).
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Figure 8. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.15 Urinary retention.
Figure 9. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.18 Blood loss by
haemoglobin levels.
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(ii) In the dermoid cyst subgroup one study only reported a single
case of fever in the laparotomy group (Morgante 1998) (Peto OR
0.14, 95% CI 0.00 to 6.82). There were no reported cases of
incision infection or urinary tract infection in this study but this
may be because all patients received prophylactic antibiotics.
(iii) In the subgroup of ovarian endometriomata (Mais 1996): no
postoperative complications were reported.
(iv) The pooled estimate for fever, including the subgroups of any
type of benign ovarian tumour and dermoid cysts, showed a re-
duced odds of febrile morbidity associated with laparoscopy (Peto
OR 0.31, 95% CI 0.13 to 0.76) with no heterogeneity detected
(Figure 5).
Blood loss assessed by haemoglobin levels
Blood loss was described in two studies (Badawy 2002;Buchweitz
2005). In one study (Buchweitz 2005) there was no statistically sig-
nificant difference between laparoscopy and laparotomy in mean
blood loss as measured by change in haemoglobin levels. In the
other study (Badawy 2002) one woman in each group had a blood
loss greater than 300 ml.
(c) Any adverse events of surgery (surgical injury, postoperative com-
plications, and any other adverse events of surgery)
(i) In the subgroup for any type of benign ovarian tumour (Badawy
2002; Buchweitz 2005; Damiani 1998; Mais 1995; Yuen 1997)
laparoscopic surgery was associated with an overall reduction in
odds of any adverse event (Peto OR 0.3, 95% CI 0.18 to 0.52),
without heterogeneity and with I2 = 0% (Figure 10).
Figure 10. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.19 Any adverse effect
of surgery (incl surgical injury or post surgery complication or other).
(ii) In the subgroup of dermoid cysts (Morgante 1998; Nitke 1996)
there were no statistically significant difference between the two
treatments arms regarding the total number of adverse events of
surgery (Peto OR 0.14, 95% CI 0.00 to 6.82). Only one case with
an adverse event was reported in one trial (Morgante 1998).
(iii) In the subgroup of ovarian endometriomata (Mais 1996) no
surgical injuries and no postoperative complications were reported
16Laparoscopy versus laparotomy for benign ovarian tumour (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in the only study analysing this subgroup.
(iv) The pooled estimate for total number of adverse events in-
cluding the subgroups of any type of benign ovarian tumour or
dermoid cysts showed a lower odds for any adverse event with la-
paroscopy compared to laparotomy (Peto OR 0.29, 95% CI 0.17
to 0.51) and no heterogeneity was detected (Figure 10).
1.3 Short-term outcomes
(a) Postoperative pain (VAS scores, free of pain at 24 to 48 hrs aft her
surgery, requirement for analgesia)
The intensity of postoperative pain was assessed in three ways:
visual analogue scores (VAS), the proportion of each group who
were pain free 24 to 48 hours after surgery, and the overall require-
ment for postoperative analgesia in each group.
(i) In the group with any type of ovarian tumour (Mais 1995;
Yuen 1997) VAS scores for pain favoured laparoscopy (WMD -
2.25, 95% CI -2.94 to -1.56); in the subgroup of dermoid cysts
laparoscopy was also associated with lower pain scores (WMD -
2.40, 95% CI -2.79 to -2.01) (Morgante 1998).
The pooled estimate for VAS scores including these two groups
favoured laparoscopy (WMD -2.36, 95% CI -2.7 to -2.03) and
no heterogeneity was detected (Chi2 = 1.78, P = 0.41, I2 = 0%)
(Figure 11).
Figure 11. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.20 Short term recovery
- pain (VAS).
(ii) The odds for being free of pain were significantly greater for la-
paroscopy in each of the three subgroups: any type of benign ovar-
ian tumour (Peto OR 5.87, 95% CI 3.48 to 9.9) (Badawy 2002;
Mais 1995; Yuen 1997); dermoid cysts (Peto OR 3.7, CI 1.42 to
9.63) (Mais 2003; Morgante 1998); and ovarian endometriomata
(Peto OR 14.51, 95% CI 3.7 to 56.9) (Mais 1996). The pooled
estimate for all the subgroups was Peto OR 7.42 (95% CI 4.86 to
11.33) with no heterogeneity detected among the 356 participants
included in these six studies (Chi2 = 4.75, P = 0.45) (Figure 12).
(iii) Two studies reported the mean postoperative consumption of
analgesics (Badawy 2002; Buchweitz 2005; Yuen 1997). Only one
study (Badawy 2002 ) found a statistically significant difference
between the groups, favouring laparoscopy.
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Figure 12. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.21 Short term recovery
- pain (pain free 24-48 hours post surgery).
(b) Recurrence of ovarian tumours six to 12 months after surgery
Recurrence was mentioned in only two studies with a combined
total of 108 participants (Damiani 1998; Mais 1995). Two cases
of recurrence (one in each group) occurred in the group with any
type of benign ovarian tumour (Damiani 1998) (Figure 13).
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Figure 13. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.23 Recurrence at 6-12
months.
(c) Length of hospital stay
Laparoscopy was associated with a reduced number of days in
hospital in all the subgroups: any type of benign ovarian tumours
(Buchweitz 2005; Damiani 1998; Mais 1995; Yuen 1997) (WMD
-2.90, 95% CI -3.28 to -2.52); dermoid cysts (Morgante 1998;
Nitke 1996) (WMD -2.93, 95% CI -3.15 to -2.70); and en-
dometriomata (WMD -2.38, 95% CI -3.01 to -1.75).
The pooled estimate for these three subgroups favoured la-
paroscopy (WMD -2.88, 95% CI -3.10 to -2.65) with hetero-
geneity (Chi2 = 11.63, P = 0.11) and inconsistency detected (I2 =
40%) (Figure 14).
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Figure 14. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.24 Length of hospital
stay (days).
(d) Readmission rates
No case of readmission was reported in any of the nine included
studies.
1.4. Economic measures
(a) Direct costs of surgical procedures
Only one study of 68 women, undertaken in Rome, Italy, de-
scribed the cost of interventions (Damiani 1998). Using a cost
analysis from a social perspective, the total costs of laparoscopy
1993 USD were significantly lower for laparoscopy when com-
pared to laparotomy (WMD USD1045, 95% CI -1348 to -742)
(Figure 15).
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Figure 15. Forest plot of comparison: 1 Laparoscopy versus laparotomy, outcome: 1.25 Economic outcomes
- total cost (US$1000 1993).
2 Laparoscopy versus minilaparotomy
2.1 Surgical outcomes
(a) Duration of surgery
Three trials (Fanfani 2004; Panici 2007; Panici 2007a) reported
the outcome of operative time but both the studies by Panici re-
ported medians as the data were skewed. The substantial hetero-
geneity and inconsistency in these results made it inappropriate to
pool these data (Chi2 = 55.56, P < 0.001) with substantial incon-
sistency (I2 = 96.4%) (Figure 16).
Figure 16. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.1 Surgery -
duration of surgery.
(b) Diagnosis of malignant tumour
One study reported inadvertent treatment by endoscopic surgery
for tumours found to be malignant on frozen section analysis dur-
ing the surgery (Panici 2007). Conversion was carried out through
an increase in the transverse cutaneous incision. Fanfani had three
cases of unexpected borderline ovarian tumour after intensive sur-
gical staging by laparoscopy (Fanfani 2004).
These studies did not report a complete five-year follow up. We
found no statistically significant difference between the two groups
(Peto OR 0.95, 95% CI 0.19 to 4.7) and no heterogeneity was
detected (Figure 17).
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Figure 17. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.2 Surgery - change
of diagnosis to malignant tumour.
2. 2 Adverse events
(a) Surgical injury
No injuries to the ureter, small bowel, colon, bladder or vascular
tissue were reported In the three studies (Fanfani 2004; Panici
2007; Panici 2007a).
(b) Postoperative complications
Blood transfusion, haematoma, thromboembolism, chemical peri-
tonitis, intestinal obstruction, and perioperative mortality were
not reported in any of the three included studies (Fanfani 2004;
Panici 2007, Panici 2007a).
One trial (Panici 2007) reported median pre- and postoperative
heamoglobin levels in each group and stated the the difference
between groups was not statitically significant.
There was no statistically significant difference between la-
paroscopy and laparotomy for febrile morbidity in two studies
(Fanfani 2004; Panici 2007a) (Peto OR 0.16, 95% CI 0.02 to
1.38) (Figure 18), nor for risk of incision infection (Peto OR 0.14,
95% CI 0.01 to 2.73) in the one trial that reported this outcome
(Panici 2007a) (Figure 19).
Figure 18. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.10 Post operative
complications - Febrile morbidity.
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Figure 19. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.11 Post operative
complications - Incison infection.
(c) Any adverse events of surgery (surgical injury, postoperative com-
plications, or any other adverse events of surgery)
The pooled estimate for odds of any adverse event favoured la-
paroscopy (Peto OR 0.10, 95% CI 0.01 to 0.77) with no hetero-
geneity detected (Fanfani 2004; Panici 2007a) (Figure 20).
Figure 20. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.19 Any adverse
effect of surgery (incl surgical injury or post surgery complication or other).
2.3 Short-term outcomes
(a) Postoperative pain (VAS scores, free of pain at 24 to 48 hrs after
surgery, requirements for analgesia)
(i) VAS scores for pain were reported in one study (Panici 2007a)
which found no statistically significant difference between la-
paroscopy and minilaparotomy (WMD -1.00, 95% CI -1.55 to -
0.45) (Figure 21).
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Figure 21. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.20 Short term
recovery - pain (VAS).
The odds for being free of pain were significantly greater for the
laparoscopy group (Peto OR 10.85, 95% CI 4.62 to 25.49) in the
one trial that reported this outcome (Panici 2007a) (Figure 22).
Figure 22. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.21 Short term
recovery - pain (pain free 24-48 hours post surgery).
Only one study reported on requirements for analgesia (Fanfani
2004) and found no difference between laparoscopy and laparo-
tomy.
(b) Length of hospital stay
(i) Mean length of stay in hospital ranged between 1 and 2.2 days
in the three studies. There was a very high level of heterogenieity
and inconsistency (I2 = 94%) which made it inappropriate to pool
these data (Figure 23).
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Figure 23. Forest plot of comparison: 2 Laparoscopy versus minilaparotomy, outcome: 2.24 Lenght of
hospital stay (days).
SENSITIVITY ANALYSES
Sensitivity analysis was performed to test the robustness of the
findings (Egger 2001) in the comparison between laparoscopy
and laparotomy. We found that the pooled estimate of treatment
effect was similar for studies with adequate and unclear allocation
concealment for the following outcomes: length of hospital stay,
postoperative pain, and total number of complications.
In the comparison between laparoscopy and minilaparotomy no
sensitivity analysis was undertaken due to the small number of
studies (Fanfani 2004; Panici 2007; Panici 2007a).
D I S C U S S I O N
This systematic review update has evaluated the benefits, harms,
and costs of laparoscopy versus laparotomy for the treatment of
benign ovarian tumours. The results of 12 randomised controlled
trials (N = 769 women) showed that laparoscopic surgery was
associated with significantly less postoperative pain, fewer adverse
events of surgery (surgical injury or postoperative complications),
and a shorter length of stay in hospital.
The results of this review give no clear information about the
operating time for the two procedures. Operating time was very
variable, and this was likely due to clinical heterogeneity in the
populations included in the trials. Variations in the age and body
mass index (BMI) of the women; the number, size, and location
(unilateral or bilateral) of the ovarian tumours; and the presence of
adhesions due to previous abdominal surgery are all factors likely
to influence the duration of surgery. Furthermore, the experience
of the surgeon, the requirement to wait for the results of an in-
traoperative frozen section, and the need to perform concomi-
tant procedures such as oophorectomy also influence the operat-
ing time. For example, in one study (Badawy 2002) only 12%
of the laparoscopy group underwent oophorectomy whereas 30%
in the laparotomy group had this procedure. Many of the studies
did not clearly describe the factors which may have accounted for
differences in the duration of surgery.
In this systematic review, the quality of allocation concealment
was graded as adequate (A) in seven studies (Badawy 2002; Mais
1995; Mais 1996; Mais 2003; Panici 2007; Panici 2007a; Yuen
1997) and five studies were graded as unclear (B) (Buchweitz 2005;
Damiani 1998; Fanfani 2004; Morgante 1998; Nitke 1996) (Table
1). The adequacy of the allocation concealment did not affect the
outcomes of duration of surgery, postoperative pain, total number
of complications, or length of hospital stay.
Although duration of hospital stay was significantly reduced, by
nearly three days, after laparoscopy when compared to laparotomy
significant heterogeneity was detected. This was likely to be due to
differences in the patient populations in the trials - factors such as
age and previous surgery may have an influence on length of stay
and it would appear that there were differences between hospitals
in their policy of postoperative stay. The data from individual
trials reported longer hospital stay after laparotomy than would be
expected and this suggests that discharge after laparotomy in some
trials may have relied more on tradition than on clinical demands.
Cost is another factor that should be taken into consideration
when choosing the surgical approach (Barnes 1982; Krahn 1999).
The costs of laparoscopy compared to laparotomy were reported
by one trial with limited sample size, with only 34 patients in
each group (Damiani 1998). This trial, undertaken in Rome, Italy,
performed a simple cost analysis from a social perspective. The
findings were that the costs of laparoscopy were USD 1000 less
per patient when compared to laparotomy (1993 costs) due to
the longer hospital stay and the increased requirement for nursing
care, medical care, laboratory tests, analgesics, antibiotics, and in-
travenous infusions in the laparotomy group. However, these data
were published many years ago and it is likely that some factors
which have an impact on costs of these procedures have changed
in the intervening period.
Overall frequency of inadvertent rupture of the cysts during op-
eration was larger in the laparoscopy group that in the minila-
parotomy group (Fanfani 2004; Panici 2007). In patients with
unrecognised neoplasms, laparoscopy may be associated with an
increase in the rate of intraperitoneal spillage with consequent
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dissemination of tumour cells and advances in disease stage (Gal
1995). Minilaparotomy has been proposed for the surgical treat-
ment of apparently benign gynecologic conditions as an alternative
minimally invasive procedure, in appropriate settings and where
patients make an informed choice after careful counselling (Panici
2007).
Since inappropriate treatment of malignant tumours by la-
paroscopy is associated with risks of tumoral spread in the ab-
dominal cavity, rupture of a malignant ovarian tumour should be
avoided during surgery (Volz 1999; Vergote 2004). Only five of the
385 women in this review who were randomised to laparoscopy
for treatment of a benign ovarian tumour were subsequently found
to have a malignant tumour. In all cases the procedure was con-
verted to laparotomy and successfully completed. Thus, we would
suggest that careful preoperative examination, as undertaken in
these studies, decreases the risk of a malignancy being identified
during a laparoscopy procedure. The standards for management
of benign ovarian tumour by laparoscopy include:
(1) careful examination of the external surface of the tumour and
sampling of the peritoneal cavity;
(2) avoidance of any tumoral rupture;
(3) protection of the ovarian tumour with an endoscopic bag before
removal;
(4) avoidance of any contact between the tumour and the abdom-
inal wall;
(5) frozen-section intraoperative histologic examination; and
(6) conversion to laparotomy when there is a suspicion that the
ovarian tumour could be borderline or malignant (Canis 2000;
Guglielmina 1997; Mettler 2001a; Nissole 1994).
The diagnostic accuracy of frozen section analysis is high for ma-
lignant and benign ovarian tumours, but accuracy is poor in the
case of borderline ovarian tumours (Medeiros 2005). However, the
incidence of borderline ovarian tumours is relatively low, around
6% compared with benign (71%) and malignant (23%) ovarian
tumours (Medeiros 2005).
It should be noted that the follow-up periods in the trials included
in this review are generally short. Seven studies had follow periods
of three months or less (Buchweitz 2005; Fanfani 2004; Morgante
1998; Nitke 1996; Panici 2007; Panici 2007a; Yuen 1997), two
studies followed women for six months (Mais 1995; Mais 1996),
two for 12 months (Badawy 2002; Damiani 1998), and only one
trial (Mais 2003) followed women (31 of the 40 women ran-
domised) for five years. Consequently we are unable to comment
on the long-term benefits or harms of laparoscopy compared to
laparotomy for benign ovarian tumours.
This review is limited in its ability to guide surgical practice because
of the small number of women randomised in the 12 studies. The
small number of randomised studies may be the result of surgeons’
resistance to accept this type of study design since only 39% of
all treatments validated in surgery are from randomised studies
(McLeod 1999; Sauerland 1999).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In this update we have found evidence, based on 12 studies with
769 women, that laparoscopic surgery for women with benign
ovarian tumours was associated with reduced pain, fewer adverse
events, and reduced time in hospital. In clinical settings where
surgical expertise and equipment are available and affordable, and
adequate preoperative evaluation is undertaken to exclude malig-
nant tumours, laparoscopic surgery can be recommended. The
decision about which surgical approach to choose should follow
careful preoperative evaluation and may take into consideration
the setting, experience of the surgeon, and the preference of the
patient.
Implications for research
There are very few trials in this field. Further trials should care-
fully address the methods of randomisation as blinding is imprac-
tical in surgical studies. Future research should include specific
patient subgroups (childbearing and non-childbearing age ranges)
and include additional outcomes such as surgical efficacy, tumour
recurrence, patient satisfaction, quality of life, and costs, with a
longer follow-up period of at least five years. This follow-up pe-
riod may provide more information on recurrence and the poten-
tially harmful effects of laparoscopy in patients who have an ovar-
ian malignancy diagnosed during the procedure. For evaluation of
costs, it would be helpful to report costs separately for the preop-
erative, intraoperative, and postoperative periods. Comparison of
cost effectiveness or cost utility of these procedures would provide
further useful information.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Badawy 2002
Methods Randomisation: randomly allocated to either treatment group using computerised ran-
dom tables (personal communication from author)
Number of women randomised: 100
Number of women analysed: 98
Number of withdrawals: 2 women in laparoscopic group were excluded after randomisa-
tion because one had diagnosis of suspected malignancy and another was excluded from
the analysis because patient had thick adhesion
Centre: one. The study was carried out between April 1997 and July 2001 in Department
of Gynaecology at Mansoura University Hospital in Egypt
Participants Inclusion: premenopausal women aged 40 years with ovarian tumour(s) which did not
meet sonographic criteria for malignancy. Tumours to be at least 3 cm and less than
15 cm in diameter, and serum CA 125 levels less than 35 U/ml. Colour doppler not
mentioned
Exclusion: preoperative or interoperative diagnosis of ovarian cancer, and no pathology
associated with an indication for hysterectomy
Age (years): 32.1 (SD 5.3) in the laparoscopy group, 34.6 (SD 6.2 ) in the laparotomy
group
Average cysts dimensions two groups were 12.4 cm (SD 2.3 cm) for laparoscopy and 13.
6 cm (SD 1.8) for laparotomy.
The histology of the surgical specimens consisted of 43 endometrioma, 27 dermoid
cysts, 24 cystadenoma, 4 paraovarian cysts. 88% (42/48) of the laparoscopy group had
cystectomy only and 70% (35/50) of the laparotomy group has cystectomy only, a
statistically significant difference
Interventions Laparoscopy for ovarian cystectomy: 4 trocar technique; enucleation of cysts by traction
and countertraction and also fenestration and cyst drainage were performed; the ovary
was sutured with Vicryl 4/0 endosuture; bipolar haemostasis; saline solutions were used
to lavage the pelvic cavity
Laparotomy for ovarian cystectomy: Pfannenstiel incision.
A standardised anaesthesia protocol was followed for all the procedures
Cystectomy was performed in 87.5% cases in laparoscopy group and 70% in laparotomy
group.
Frozen section was not mentioned in the trial report.
Outcomes Operative time, intraoperative blood loss, complications, conversion to laparotomy, post-
operative complications, analgesic requirements, hospital stay
Intention to treat analysis Not mentioned but 98% of women randomised were included in the analysis
Power calculation described No
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Badawy 2002 (Continued)
Notes Follow up: 10, 30, and 365 days after surgery evaluated clinically, and asked to complete
a standard questionnaire concerning return to their normal lifestyle or any complications
and improvement in their symptoms
Conversions to laparotomy: 2 cases.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Low risk A
Personal communication from Dr Badawy
confirmed that participants in this study
were randomly allocated to either treat-
ment group using computerised random
tables. Randomisation was done on admis-
sion of the patients to the hospital by the
principal investigator. However, it was not




Incomplete outcome data addressed?
All outcomes
High risk 2 women in laparoscopy group were ex-
cluded after randomisation because one
had diagnosis of suspected malignancy and
the other was excluded from the analysis
because of a thick adhesion
Free of selective reporting? Low risk
Buchweitz 2005
Methods Randomisation: method not stated
Blinding: not mentioned
Number of women randomised: 23
Number of women analysed:20
Number of withdrawals: 1 woman in each group was excluded after randomisation
because the diagnosis changed to malignancy and another was excluded from the analysis
because her IL-6 level on admission was very high (an extreme outlier)
Centre: one; the study was carried out between January 2001 and August 2002 in
Departament of Gynecology at a university hospital in Germany
Participants Inclusion: consecutive patients older than 60 years with ovarian tumour(s), which did
not meet sonographic criteria for malignancy. Tumours to be at least 3 cm and less than
8 cm in diameter, and serum CA 125 levels less than 35 U/ml. Colour doppler not
mentioned
Exclusion: preoperative or interoperative diagnosis of ovarian cancer, and treatment with
’high doses’ of corticoids
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Buchweitz 2005 (Continued)
Age (years): 66.5 (SD 5.8) in the laparoscopy group, 68.8 (SD 6.9 ) in the laparotomy
group
Average cysts dimensions: two groups were 4.8 cm (SD 1.3) for laparoscopy and 4.0 cm
(SD 1.0) for laparotomy.
The anatomicopathologic study of surgical specimens identified 11 adenofibroma, 4
serous cystadenoma, 1 mucous cystadenoma, and 4 functional cysts with no differences
between the 2 groups
Interventions Laparoscopy for oophorectomy: 3 trocar technique, the ovarian tumours were placed in
a disposable plastic bag and removed via the suprapubic port. All adnexal masses were
sent for immediate frozen section and If malignancy was detected the procedure was
converted to laparotomy
Laparotomy for ovarian cystectomy: Pfannenstiel incision.
A standardised anaesthesia protocol was followed for all the procedures
Bilateral oophorectomy was performed in 50% cases in laparotomy group and 40% in
laparoscopy group
Frozen section was mentioned in the trial.
Outcomes Interleukin 6, C reactive protein levels (objective stress response), operative time, esti-
mated blood loss by haemoglobin drop, postoperative pain duration and requirements
for analgesia, hospital stay, convalescence
Intention to treat analysis No
Power calculation described It was calculated that 10 women would be required in each group in order to have 90%
power, at the 0.05 level of significance, to detect a 30% reduction in serum interleukin-
6 (IL-6) levels from the peak
Notes Follow up was mentioned (3 months).
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
High risk 23 women were randomised; 2 women
were found to have malignant tumours in-
traoperatively (1 from each group) and 1
woman was found to have a very high IL-
6 level (at some point) so 3 women were
excluded from the analysis
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Buchweitz 2005 (Continued)
Free of other bias? Unclear risk 3 patients excluded from analysis postran-
domisation.
Damiani 1998
Methods Randomisation: method not stated
Blinding: not mentioned
Centre: one
Number of women randomised: 68
Number of women analysed: 68
The study was carried out between January 1992 and November 1994 in the Endocrino-
logical Gynaecology Department of Catholic University S Cuore in Rome, Italy
Participants Inclusion: women of reproductive age with ovarian cysts which had persisted for at
least 3 months or were noted to have increasing volume on consecutive ultrasound.
Cyst diameter less than 10cm, liquid content, thin walls without septa, unilocular cysts
without irregular solid parts inside the cyst. CA 125 levels and colour Doppler not
mentioned
Exclusion: previous pelvic surgical interventions.
Age (years): 28.6 (SD 6.2; range 16-38) in the laparoscopy group and 27.3 (SD 6.2;
range 18-39) in the laparotomy group
Average cyst dimensions: 6.6 cm (SD 1.6; range 3-9 cm) for laparoscopy and 6.6 cm
(SD 1.7; range 4-10 cm) for laparotomy.
All laparoscopy surgery was performed by a team which had several years experience.
Histological findings in laparoscopy group (number of cases): serosal (3); mucinous (4)
; endometriotic (8); functional (12); paraovarian (2); dermoid (5).
Histological findings in laparotomy group (number of cases): serosal (5); mucinous (2);
endometriotic (10); functional (11); paraovarian (3); dermoid (3)
Interventions Laparoscopy for ovarian cystectomy: 3 trocar technique; enucleation of cysts by traction
and countertraction and also fenestration and cyst drainage were performed; excised tissue
were placed in a disposable plastic bag, the ovary was not sutured; bipolar haemostasis;
saline solutions were used to lavage the pelvic cavity; all patients received intraoperative
prophylactic antibiotic therapy.
Laparotomy for ovarian cystectomy: Pfannenstiel incision; all cases ovarian was sutured
in two layers; used 0 polyglactin for internal layer and 6-0 polyglactin suture for the
external surface; all patients received intraoperative prophylactic antibiotic therapy.
Anaesthesia protocol not described.
Frozen section was not mentioned in the trial.
Outcomes Costs of interventions in USD (direct, indirect), operation time, length of stay
Intention to treat analysis Not stated, but all women appeared to be included in the analysis
Power calculation described No
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Damiani 1998 (Continued)
Notes Follow up for 12 months with one recurrence in each group (one endometrioma and one
mucinous cystadenoma). Number of women excluded, number of women withdrawn
and lost to follow up not stated. Conversions to laparotomy: unknown
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Unclear risk No information given.
Fanfani 2004
Methods Randomisation: centralised and computer based, performed on the day of surgery
Blinding: none
Centre: one
Number of women randomised:100
Number of women analysed:100
This trial was carried out between January and August 2003 at the Department of Gynecologic
Oncology, University of the Sacred Heart, Rome, Italy
Participants 100 consecutive women were randomised.
Inclusion: adnexal mass, presumed to be benign, requiring surgical treatment
Exclusion: BMI greater than 32 kg/m2, cyst(s) greater than 12 cm in diameter, postmenopausal women
with serum CA 125 level greater than 35 IU/ml, requirement for hysterectomy at same time
All women underwent standard preoperative assessment including serum markers, an ultrasound scan
with colour Doppler evaluation to assess the size and characteristics of the lesions
Age (years): 36.3 (SD 12.1) in the laparoscopy group and 37.5 (SD 13.4) in the minilaparotomy group
Histopathological diagnosis: endometriotic cysts (n=33), benign ovarian and parasalpingoserous cysts
(n=32), dermoid cysts (n=18), benign mucinous cysts (n=16). Only accounts for 99/100
Interventions All surgical procedures, both laparoscopy and minilaparotomy were performed by one senior surgeon
and one fellow. Intraoperative frozen section performed if required
Bowel preparation and antithrombotic prophylaxis always performed and second generation
cephalosporin administered to all women. General anaesthesia given to all women. Decision on cys-
tectomy versus oophorectomy made based on operative findings and age of patient
Laparoscopy: 4 trocar technique, 10 mm transluminal port for the laparoscope and three 5mm ports
right, left, and sovrapubic. Enucleation by traction and counter traction and fenestration and cyst
drainage were performed. The ovary was not sutured
Minilaparotomy: a 4-9 cm transverse incision 1-2 cm below the pubic hair line, end of incision sutured
to avoid accidental lengthening. Vertical incision used where patient had previous longitudinal scar.
Local anaesthetic also given if operating time exceeded 2 hours
Frozen section was mentioned in the trial.
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Fanfani 2004 (Continued)
Outcomes Operative time, intraoperative blood loss, complications, conversion to laparotomy, postoperative
complications, change of diagnosis to malignant
Intention to treat analysis Not mentioned but 99 of the 100 women randomised were accounted for in the analysis
Power calculation described Power stated to be >80% but no details given.
Notes Follow-up period of 30 days.
Risk of bias
Bias Authors’ judgement Support for judgement




Free of other bias? Low risk consecutive patients.
Mais 1995
Methods Randomisation: using random numbers table, with allocation in sealed envelopes. The
envelope seal was broken in the anaesthetic room before surgery
Blinding: no
Centre: one
Number of women randomised: 40
Number of women analysed: 40
The study was carried out between January 1993 to June 1994 in the Department of
Obstetrics and Gynecology of the University of Cagliari, Cagliari, Italy
Participants Inclusion: premenopausal (18-40 years) women with ovarian tumours, assumed to be
benign, which had persisted for more than 6 months, diameter less than 10 cm. All
women were submitted to a preliminary workup, including ultrasonography. CA 125
levels and colour Doppler not mentioned
Exclusion: women unfit for general anaesthesia, those with systemic infections, and those
unable to give informed consent
Age (years): 30.4 (SD 6.1) in the laparoscopy group and 29.8 (SD 6.4) in the laparotomy
group
Average cyst dimensions: in two groups were 6.7 cm (SD 1.6) for laparoscopy and 6.3
cm (SD 1.7) for laparotomy
Histological findings in laparoscopy (number of cases): serous paratubal (8); serous ovar-
ian (10); serous cystadenoma (0); mucinous cystadenoma (2)
Histological findings in laparotomy (number of cases): serous paratubal (6); serous ovar-
ian (12); serous cystadenoma (1); mucinous cystadenoma (1)
All surgical procedures were performed by the same investigators
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Mais 1995 (Continued)
Interventions Laparoscopy for ovarian cystectomy: 3 trocar technique; enucleation of cysts by traction
and countertraction and also fenestration and cyst drainage were performed; the ovary
was not sutured; saline solution used to lavage the pelvic cavity.
Laparotomy for ovarian cystectomy: Pfannenstiel incision.
The procedures were performed under general anaesthesia.
Frozen section was not mentioned.
Outcomes Numbers in each group analgesic free at day 2, discharged from hospital within 3 days,
and fully recuperated at day 15, difference in mean VAS score for pain, operative time,
hospital stay
Intention to treat analysis Yes
Power calculation described Calculated that the sample size of 40 (20 in each group) would provide 90% power to
detect a difference, at the 5% significance level, in the outcomes of analgesic free at day 2,
discharged from hospital within 3 days, and fully recuperated at day 15. Also calculated
that sample size of 40 would provide more than 90% power at the 5% significance level
to detect a difference of 2cm between group means on the visual analogue scale for pain
Notes Follow up: 15, 30, 90 and 180 days after surgery (clinical examination and ultrasono-
graphic scan); 83 women were screened, underwent ultrasound evaluation, and 6 months
expectant management. After 6 months 32 women whose cysts resolved spontaneously
were excluded from surgery. Of the remainder if cyst was still present (n=38) or if cyst
size was increased (n=13) surgery was planned. Of these, 2 women were deemed unfit
for anaesthesia, 1 had a systemic infection, and 1 had a psychiatric condition which
excluded her from study. A further 7 women refused randomisation
All cysts were found to be benign.
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Low risk
Free of selective reporting? Low risk
Free of other bias? Low risk
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Mais 1996
Methods Randomisation: table of random digits
Allocation concealed in numbered sealed envelopes and the seal was broken in the
anaesthetic room before surgery
Centre: one
Number of women randomised: 32
Number of women analysed: 32
The study was carried out between January 1993 and June 1994 in the Department of
Obstetrics and Gynecology of the University of Cagliari, Cagliari, Italy
Participants Inclusion: premenopausal (18-40 years) women without acute pelvic symptoms and
with hypoechoic, unilateral, unilocular persistent ovarian cysts, 3-10 cm in diameter,
suspected to be endometrioma by transvaginal sonography. CA 125 levels and colour
Doppler not mentioned
Exclusion: unfit for general anaesthesia, systemic infection, or unable to give informed
consent
Age (years): 30.1 (SD 5.8) in the laparoscopy group, 31.2 (SD 6.3) in the laparotomy
group
Average cyst dimensions were: 5.4 cm (SD 2.0) for laparoscopy and 5.5 cm (SD 2.1) for
laparotomy
Histological findings in laparoscopy and laparotomy group: all cases were endometrioma
Interventions Laparoscopy for ovarian cystectomy: 3 trocar technique; enucleation of cysts by traction
and countertraction and also fenestration and cyst drainage were performed; the ovary
was not sutured; saline solution used to lavage the pelvic cavity
Laparotomy for ovarian cystectomy: Pfannenstiel incision.
All procedures were performed by the same investigators and women were given general
anaesthesia
Frozen section was not mentioned in the trial report.
Outcomes Operative time, analgesic requirement, pain (VAS scale), number of women in each
group analgesic free at day 2, proportion of women in each group discharged from
hospital by day 3
Intention to treat analysis Not mentioned, but all women randomised appeared to be included in the analysis
Power calculation described It was calculated that a sample size of 32 would provide a power of 90% to detect
a difference, at the 5% significance level, in the proportion of women in each group
analgesic free at day 2, discharged from hospital by day 3, and fully recuperated at day
15
Notes Follow up: 15, 30, 90, and 180 days after surgery (clinical examination and ultrasono-
graphic scan); number of women excluded, number of women withdrawn and lost to
follow up. No details given; conversions to laparotomy unknown
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Low risk A
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Incomplete outcome data addressed?
All outcomes
Low risk All women randomised were included in
the analysis.
Free of selective reporting? Low risk
Free of other bias? Low risk
Mais 2003
Methods Randomisation by the use of a random digits
Allocation concealed in sealed envelopes. The envelope seal was broken in the anaesthetic
room before surgery
Centre: one
Number of women randomised: 40
Number of women analysed: 40 for most outcomes, with 5-year follow up on 31 women
The study was carried out between December 1992 and January 1996 in the Department
of Obstetrics and Gynecology of the University of Cagliari, Cagliari, Italy
Participants Inclusion: women without symptoms; of reproductive age (19-43 yrs) with one unilateral
persistent ovarian cyst which was suspected to be a dermoid ovarian cyst (teratoma)
by ultrasonography, diameter less than 10 cm. CA 125 levels and colour Doppler not
mentioned
58 women were screened and underwent abdominal and transvaginal ultrasonography.
One woman was deemed unfit for general anaesthetic, two had systemic infections, and
one had a psychiatric condition which precluded informed consent, so were excluded.
A further 5 women were excluded because their cyst diameter exceeded 10 cm
Age (years): 31.4 (SD 6.1) in the laparoscopy group and 30.7 (SD 5.5) in the laparotomy
group
Average cysts dimensions were: 5.8 cm (SD 1.3 cm) for laparoscopy and 6.1 cm (SD 1.
5 cm) for laparotomy groups
Interventions Laparotomy: a Pfannestiel incision was always used for laparotomy. Laparoscopy 10 mm
port was inserted through the umbilicus to introduce the laparoscope. Two additional 5
mm ports were inserted in the right and left lower abdominal quadrants for introduction
of surgical instruments. A fourth 10 mm port was introduced in the midline 4 cm above
the symphysis pubis for introduction of endoscopic bag. After the ovary was grasped with
atraumatic forceps, a superficial incision of ovarian cortex was made with scissors. The
incision was gently enlarged to locate the cleavage plane between the cyst wall and the
ovarian cortex. Bipolar coagulation and scissors were used to separate fibrous adhesions.
During laparoscopy procedures, the cyst was inserted into an endoscopic bag which
was closed by pulling the drawstring. The drawstring and the margins of the bag were
removed from the abdominal cavity through the suprapubic port
During both laparotomy and laparoscopy careful exploration of the pelvis and the ab-
domen was performed for evidence of malignancy. During both laparotomy and la-
paroscopy, the ovary was left open without sutures
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Mais 2003 (Continued)
If unintended spillage of the cyst contents occurred, a copious saline solution was used
to irrigate the pelvic cavity. Any particulate material was carefully grasped and removed
Minimal or mild spillage occurred in nine women (seven laparoscopy and two laparo-
tomies) but the postoperative course was always uneventful
Frozen section was not mentioned in the trial report.
Outcomes Operative time, analgesic requirement, hospital stay, (reported in Mais 1995 and Mais
1993) recurrence rate over 5 years follow up
Intention to treat analysis Not mentioned, but all women randomised appeared to be included in the primary
analysis
Power calculation described No
Notes A 5-year follow up of 31 of the 40 women originally randomised. Reasons for loss of
data on 9 women were described
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Low risk In the laparoscopy group 2 women were
lost to follow up after 2 years, one lost after
2.5 years, and a further 2 lost after 3 years (2
of these due to pregnancy). In the laparo-
tomy group 2 women were lost to follow
up after 2.5 years and a further 2 were lost
after 4 years (1 of these due to pregnancy)
Free of selective reporting? Low risk
Free of other bias? Low risk
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Morgante 1998
Methods Randomisation: random number table
RCT: method of randomisation unclear
Blinding: not mentioned
Centre: one
Number of women randomised: 44
Number of women analysed: 44
The study was carried out between January 1992 and 31 December 1996 in the Depart-
ment of Obstetrics and Gynecology of the University of Siena, Siena, Italy
Participants Inclusion: women of reproductive age (14-42 yrs) with dermoid ovarian cysts, assumed
to be benign, with diameter less than 12 cm. CA 125 levels and colour Doppler not
mentioned
Age (years): 29.4 (SD 6.8; range 15-40) in the laparoscopy group, 30.3 (SD 8.3; range
14-42) in the laparotomy group
The average cyst dimension were: 6.7 cm (range 4-12) for laparoscopy and 6.5 cm (range
4-12) for laparotomy
Histological findings were dermoid ovarian cyst but in association with other histological
types: functional nature (17.2%), endometriotic (4.5%), serous cystadenomas (5.3%),
mucinous cystadenoma (1.2%). Dermoid cysts were bilateral in 7.9% of cases
Interventions With both procedures the pelvic cavity was examined for signs of malignancy, and all
women received prophylactic antibiotics to prevent infection
40 of the 44 women underwent transabdominal and transvaginal ultrasound prior to
surgery; 4 who did not were young women who had never had sexual intercourse
Laparoscopy for ovarian cystectomy: 4 trocar technique; enucleation of cysts by traction
and countertraction; aspiration of the cysts and after the capsule was removed in such
a way as to avoid spillage of cyst fluid into the abdominal cavity. Bipolar cautery for
haemostasis. When spillage occurred (six cases) saline solution used to lavage the pelvic
cavity. Ovary was not sutured.
Laparotomy for ovarian cystectomy: details were not given.
No details were given concerning anaesthetic protocol.
Frozen section was not mentioned in the trial report.
Outcomes Duration of surgery, mean blood loss, mean length of hospital stay, postoperative com-
plications, pain, requirement for analgesics, return to work
Intention to treat analysis Not mentioned, but all women randomised appeared to be included in the analysis
Power calculation described No
Notes Follow up 2 weeks: no details given; number of women excluded, number of women
withdrawn and lost to follow up
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk B
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Incomplete outcome data addressed?
All outcomes
Low risk
Free of selective reporting? Low risk
Free of other bias? Low risk
Nitke 1996
Methods Randomisation: method not stated
Blinding: not mentioned
Centre: one
Number of women randomised: 38
Number of women analysed: 38
The study was carried out between 1992 and 1995 in the Department of Obstetrics and
Gynecology of the Rabin Medical Center, Tel Aviv, Israel
Participants Inclusion: women of reproductive age (16-39 yrs) with dermoid ovarian cysts. All women
were submitted to a preliminary workup, including ultrasonography, CA 125, as well as
colour Doppler ultrasonography to exclude malignancy
Exclusion: women with contraindications to laparoscopy - gross obesity, bowel disease,
massive adhesions following previous surgery, a large abdominal mass, and cardiorespi-
ratory disorders
Age (years): 27.7 (SD 6.8; range 16-39) in the laparoscopy group and 24.3 (SD 5.2;
range 17-38) in the laparotomy group
No information provided on average cyst dimensions in each group.
Histological findings in laparoscopy and laparotomy group: all cases were dermoid ovar-
ian cyst
Interventions The procedures were performed under general anaesthesia and the pelvic cavity was thor-
oughly inspected for signs of malignancy. Laparoscopy for ovarian cystectomy: 3 trocar
technique; enucleation of cysts by traction and countertraction; the ovary was not su-
tured; In 10 cases the cyst was removed intact, and in the remainder the cyst was aspirated
to remove fluid and the capsule was removed in such a way as to minimise spillage of cyst
fluid into the abdominal cavity; electrocoagulation for haemostasis; Ringers solution was
used to lavage the pelvic cavity.
Laparotomy for ovarian cystectomy: Pfannenstiel incision (minilaparotomy); in all cases
ovarian resection by conservative enucleation followed by suture of the ovary in two
layers. When spillage occurred the pelvic cavity was lavaged with ringers solution.
Frozen section was not mentioned in the trial.
Outcomes Operative time; length of stay in hospital, complications; hospital stay
Intention to treat analysis Not mentioned but all women randomised appeared to be included in the analysis
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Nitke 1996 (Continued)
Power calculation described No
Notes Follow up: no details given.
Number of women excluded, number of women withdrawn and lost to follow up: no
details given
Conversions to laparotomy: unknown. Table 2 gives a list of concomitant procedures
performed during laparoscopy which may have influenced duration of operation
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Low risk
Free of other bias? Low risk
Panici 2007
Methods Randomisation: omputerised randomisation list was independently generated and al-
location to treatment arms was recorded in sequentially numbered sealed envelopes by




Number of women randomised: 60
Number of women analysed: 60 (primary endpoint)
The study was conducted between January 2005 and September 2006 in the Department
of Obstetrics and Gynecology, la Sapienza University, Rome, Italy and Department of
Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
Participants All patients had a preoperative assessment of transabdominal and transvaginal ultrasound
including estimation of cyst size. Colour Doppler not mentioned
Inclusion: women aged 18-45 years with large (7-18 cm) apparently benign, non-en-
dometriotic adnexal cysts, serum CA125 in the normal range, BMI less than 29 kg/m2,
American Society of Anaesthesiologists physical status classification 0-2, no known acute
or chronic pelvic disease, no previous laparotomies, no requirement for other associated
surgical procedures, possibility of placing an intrauterine manipulator, and signed in-
formed consent to the procedure and to traditional surgical staging in case of unexpected
malignancy
Exclusion: identification of peritoneal signs of malignancy during diagnostic laparoscopy,
inadequate surgical field for minilaparotomy
Median age (years): 31 (range 24-36) in the laparoscopy group and 29 (range 34-35) in
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Panici 2007 (Continued)
the minilaparotomy group
Median cyst dimensions were: 8.4 (range 8-12.2) in the laparoscopy group and 8.2 (range
7.9-10.4) in the minilaparotomy group
Interventions No mechanical bowel preparation was performed and all patients had antithrombotic
(low molecular weight heparin) and antibiotic (IV cefalotin) prophylaxis. All women
underwent diagnostic open laparoscopy and if the inclusion/exclusion criteria were satis-
fied a sequentially numbered sealed envelope was opened in theatre to determine which
procedure then followed
Laparoscopy: 3 additional ports were inserted. Plane of cleavage was located with the
aid of grasping forceps and cyst capsule was separated from the ovarian cortex using
diverting traction; ancillary port in the sovrapubic region was enlarged to fit a 10 mm
trocar for insertion of an endobag. Wherever possible unruptured cyst was placed in bag
to contain spillage, or controlled cyst aspiration was carried out under direct view
Haemostasis by bipolar coagulation. Peritoneal cavity was copiously rinsed with Ringers
solution, and 1000ml was left in cavity for adhesion prevention
Minilaparotomy: 3-7 cm transverse incision 1-2 cm below pubic hair line and 2-4 cm
above pubic symphysis was made based on the finding of the diagnostic laparoscopy.
Where possible the cyst was delivered outside the abdomen through the incision. Alter-
natively the cyst was aspirated and cyst wall rupture site controlled with a clamp. Excision
of the cyst was performed in standard fashion and the ovarian edges approximated with a
suture stitch avoiding the ovarian cortex; haemostasis by bipolar coagulation, peritoneal
lavage using copious Ringers solution
Intraoperative frozen section was routinely performed.
Six patients in laparoscopy group were not treated per protocol: three were converted to
laparoscopically guided minilaparotomy, one was converted to a Pfannanstiel incision
(diagnosis of malignancy), and two a low vertical incision
Two patients in minilaparotomy group were not treated as per protocol; in both increase
in transverse incision was made due to technical difficulties
Frozen section was mentioned in the trial report.
Outcomes Primary outcome was uncontrolled cyst spillage and/or rupture rate, secondary outcomes
surgical difficulty, operative and postoperative results, short and long-term complications,
and short-term patient satisfaction
Intention to treat analysis Yes
Power calculation described Sample size was calculated to detect with 80% power at the 0.05 alpha level a difference
in 40% in rupture rate given a reference rate of 80% for patients treated with operative
laparoscopy reported in our previous study
Notes Relative risk of cyst rupture of laparoscopy group versus laparoscopy guided minilaparo-
tomy was 5.55 (95% CI 1.88 to 16.33). Spillage of cyst contents occurred in 21 and 8
patients respectively. Follow up 3 months
Risk of bias
Bias Authors’ judgement Support for judgement
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Incomplete outcome data addressed?
All outcomes
Low risk
Free of selective reporting? Low risk
Free of other bias? Low risk
Panici 2007a
Methods Randomisation: allocation to treatment arms was recorded in a blind envelope system;
envelopes were opened in theatre after initial laparoscopy had been performed
Blinding: none
Centres: two
Number of women randomised: 127
Number of women analysed: 127
The study was conducted between July 2002 and June 2004 in the Department of
Obstetrics and Gynecology, la Sapienza University, Rome, Italy and Department of
Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
Participants All women underwent preoperative transabdominal and transvaginal ultrasound on the
day before surgery. Surgery was performed under general endotracheal anaesthesia. In
postmenopausal women bilateral salpingo-oophorectomy was performed
Inclusion: women aged more than 16 years and less than 70 years with apparently
benign adnexal cysts of less than 10 cm diameter, absence of ultrasonographic evidence
of malignancy, serum CA125 in the normal range for postmenopausal women, BMI
less than 29 kg/m2, American Society of Anaesthesiologists physical status classification
0-2, no known acute or chronic pelvic disease, no previous laparotomies, and signed
informed consent
Exclusion:
127 women were randomised: 63 to laparoscopy group and 64 to minilaparotomy group
Median age (years): 30 (range 17-70) in the laparoscopy group and 32 (range 16-65) in
the minilaparotomy group
Median cyst dimensions were: 5.5 (range 3.5-9.5) in the laparoscopy group and 5.2
(range 3.2-9) in the minilaparotomy group
Interventions Laparoscopy via 4 ports. Careful exploration of the pelvis and abdomen for visual exclu-
sion of malignancy. Adhesions were lysed and the cyst capsule was separated from the
ovarian cortex using diverging tractions. Haemostasis by bipolar coagulation. Ovary left
unsutured. Cyst was removed from the abdominal cavity using an endobag; Intraopera-
tive frozen section was always performed
Minilaparotomy: 3-7 cm transverse incision, 1-2 cm below pubic hairline and 2-4 cm
above the pubic symphysis; laparoscope was introduced through the incision to explore
the abdominal cavity; if the size of cyst did not permit its delivery through the incision or
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Panici 2007a (Continued)
if the cyst ruptured during mobilisation, cyst content was aspirated, cyst wall rupture site
controlled with clamp, and then the cyst was delivered with minimum spillage. Ovaries
were left unsutured
Intraoperative frozen section was performed.
Outcomes Operating time, blood loss, pain, time to recovery to regular bowel movements, tolerance
of liquid diet, mobility around the ward, duration of postoperative stay. Intraoperative
and postoperative complications
Intention to treat analysis All women randomised were accounted for in the analysis
Power calculation described No
Notes Follow up 3 months.
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Low risk
Free of selective reporting? Low risk
Free of other bias? Low risk Consecutive patients.
Yuen 1997
Methods Randomisation: computer-generated numbers were used to assign the surgical approach
and were placed in sealed opaque consecutively numbered envelopes
Blinding: not mentioned
Centre: one
Number of women randomised: 102
Number of women analysed: 102
The study was carried out between July 1994 and September 1995 in the Department
of Obstetrics and Gynaecology, Prince of Wales Hospital, Hong Kong
Participants All women had standard preoperative assessment with an ultrasound scan, usually
transvaginal. Postmenopausal women had serum CA 125 levels measured. Colour
Doppler not mentioned
Inclusion: women requiring surgical management of benign ovarian tumours
Exclusion: women where ultrasonic scan suggested a malignancy, tumour greater than
10 cm diameter, or requirement for concurrent hysterectomy
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Yuen 1997 (Continued)
Age (years): 35.1 (SD 10.3) in the laparoscopy group and 34.7 (SD 8.8) in the laparotomy
group
Average cyst dimensions in two groups were: 5.6cm (SD 1.8 cm) for laparoscopy and 5.
7cm (SD 2.1 cm) for laparotomy
Interventions All procedures were performed under general anaesthesia. All surgical procedures were
performed by physicians undergoing training under the supervision of an experienced
surgeon. Frozen section was not mentioned in the trial.
Laparoscopy: 3 trocar technique; procedures were cystectomy or oophorectomy; excised
tissue was placed in a disposable plastic bag; bipolar haemostasis; oophorectomy was
performed in 27.6% of cases in the laparoscopy group.
Laparotomy: Pfannenstiel incision or subumbilical midline incision; procedures were
cystectomy or oophorectomy; not stated whether ovary was sutured. Oophorectomy was
performed in 25% of cases in the laparotomy group
Outcomes Operative time; operative blood loss, postoperative pain, intraoperative complications,
postoperative complications, hospital stay, return to work
Intention to treat analysis Not mentioned but 102 of the 106 women randomised were included in the analysis
Power calculation described Yes, sample size of 100 women was calculated to provide 90% power at a significance
level of 5% to find a difference in operative morbidity
Notes Follow up: 8 weeks; 4 women excluded because they refused randomisation and 4 women
lost to follow up, no details given. All ovarian tumours benign
Risk of bias
Bias Authors’ judgement Support for judgement




Incomplete outcome data addressed?
All outcomes
Low risk
Free of selective reporting? Low risk
Free of other bias? Low risk
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Albini 1994 Not randomised
Bateman 1994 Not randomised
Bulletti 1996 Not randomised
Chapron 1997 Not randomised
Darwisch 2001 Not randomised
Deckardt 1994 Not randomised, even though it claimed to be (allocation to different wards by an admitting clerk is NOT
a method of randomisation, and it is not likely to result in groups which are equal and balanced with regard
to all possible known and unknown confounding factors. This is evidenced by the numerically unbalanced
groups which resulted (n=116 versus n=76))
Hidlebaugh 1994 Not randomised
Hidlebaugh 1997 Not randomised
Howard 1995 Not randomised
Laberge 2006 Not randomised
Lin 1995 Not randomised
Marana 2004 Not randomised
Mettler 2001 Not randomised
Papasakelariou 1995 Not randomised
Paredes 1997 Not randomised
Pittaway 1994 Not randomised
Quinlan 1997 Not randomised
Thomas 2006 Not randomised
Yuen 1995 Not randomised
Zanetta 1999 Not randomised
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D A T A A N D A N A L Y S E S
Comparison 1. Laparoscopy versus laparotomy




participants Statistical method Effect size
1 Surgery - Duration of surgery
(min)
9 Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 Any type of benign
ovarian tumour
5 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Dermoid cysts 3 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 Ovarian endometriomata 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2 Surgery - Change of diagnosis to
malignant tumour
8 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
2.1 Any type of benign
ovarian tumour
4 230 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.12, 8.46]
2.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Surgical Injury - Bladder 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
3.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.13 [0.00, 6.56]
3.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Surgical Injury - Ureter 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
4.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Dermoid cysts 3 118 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Surgical Injury - Vascular 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
5.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 7.40 [0.46, 118.39]
5.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Surgical Injury - Small bowel 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
6.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Surgical Injury - Colon 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
7.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Post operative complications -
Blood transfusion required
9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
8.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
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9 Post operative complications -
Haematoma
9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
9.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Post operative complications -
Febrile morbidity
9 482 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.36 [0.18, 0.73]
10.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.37 [0.18, 0.76]
10.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.14 [0.00, 6.82]
10.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Post operative complications -
Incision infection
9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
11.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.23 [0.05, 1.05]
11.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Post operative complications -
Urinary tract infection
9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
12.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.30 [0.08, 1.16]
12.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Post operative complications -
Thromboembolism
9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
13.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.12 [0.01, 2.09]
13.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Blood loss by hemoglobin levels 1 20 Mean Difference (IV, Random, 95% CI) -0.30 [-1.31, 0.71]
14.1 Any type of benign
ovarian tumour
1 20 Mean Difference (IV, Random, 95% CI) -0.30 [-1.31, 0.71]
14.2 Dermoid cysts 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
14.3 Ovarian endometriomata 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
15 Perioperative mortality 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
15.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Urinary retention 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
16.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.12 [0.02, 0.89]
16.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Chemical peritonitis 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
17.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Intestinal obstruction 9 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
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18.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.14 [0.00, 6.82]
18.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 1.18 Any adverse effect of
surgery (incl surgical injury or
post surgery complication or
other)
9 482 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.29 [0.17, 0.51]
19.1 Any type of benign
ovarian tumour
5 328 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.30 [0.18, 0.53]
19.2 Dermoid cysts 3 122 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.13 [0.01, 2.13]
19.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Short term recovery - pain
(VAS)
3 186 Mean Difference (IV, Fixed, 95% CI) -2.36 [-2.70, -2.03]
20.1 Any type of benign
ovarian tumour
2 142 Mean Difference (IV, Fixed, 95% CI) -2.25 [-2.94, -1.56]
20.2 Dermoid cysts 1 44 Mean Difference (IV, Fixed, 95% CI) -2.4 [-2.79, -2.01]
21 Short term recovery - pain
(painfree 24-48 hours post
surgery)
6 356 Peto Odds Ratio (Peto, Fixed, 95% CI) 7.42 [4.86, 11.33]
21.1 Any type of benign
ovarian tumour
3 240 Peto Odds Ratio (Peto, Fixed, 95% CI) 5.87 [3.48, 9.90]
21.2 Dermoid cysts 2 84 Peto Odds Ratio (Peto, Fixed, 95% CI) 10.68 [4.55, 25.06]
21.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 14.51 [3.70, 56.90]
22 Short term recovery - Pain
(requirement for analgesia)
Other data No numeric data
22.1 any type of benign
ovarian tumour
Other data No numeric data
23 Recurrence at 6-12 months 4 171 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.06, 16.33]
23.1 Any type of benign
ovarian tumour
2 108 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.06, 16.33]
23.2 Dermoid cysts 1 31 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.3 Ovarian endometriomata 1 32 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Length of hospital stay (days) 8 442 Mean Difference (IV, Random, 95% CI) -2.88 [-3.11, -2.66]
24.1 Any type of benign
ovarian tumour
5 328 Mean Difference (IV, Random, 95% CI) -2.91 [-3.28, -2.55]
24.2 Dermoid cysts 2 82 Mean Difference (IV, Random, 95% CI) -2.93 [-3.15, -2.70]
24.3 Ovarian endometriomata 1 32 Mean Difference (IV, Random, 95% CI) -2.38 [-3.01, -1.75]
25 Economic outcomes - total cost
(US$1000 1993)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
25.1 Any type of benign
ovarian tumour
1 68 Mean Difference (IV, Fixed, 95% CI) -1045.0 [-1347.94, -
742.06]
25.2 Dermoid cysts 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.3 Ovarian endometriomata 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 2. Laparoscopy versus minilaparotomy




participants Statistical method Effect size
1 Surgery - duration of surgery 3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Surgery - change of diagnosis to
malignant tumour
2 160 Odds Ratio (Peto, Fixed, 95% CI) 2.37 [0.34, 16.61]
2.1 Any type of benign
ovarian tumour
2 160 Odds Ratio (Peto, Fixed, 95% CI) 2.37 [0.34, 16.61]
3 Post operative complications -
Febrile morbidity
2 227 Odds Ratio (Peto, Fixed, 95% CI) 0.16 [0.02, 1.38]
3.1 Any type of benign
ovarian tumour
2 227 Odds Ratio (Peto, Fixed, 95% CI) 0.16 [0.02, 1.38]
4 Post operative complications -
Incison infection
1 127 Odds Ratio (Peto, Fixed, 95% CI) 0.14 [0.01, 2.73]
4.1 Any type of benign
ovarian tumour
1 127 Odds Ratio (Peto, Fixed, 95% CI) 0.14 [0.01, 2.73]
5 Any adverse effect of surgery
(incl surgical injury or post
surgery complication or other)
2 227 Odds Ratio (Peto, Fixed, 95% CI) 0.10 [0.01, 0.77]
5.1 Any type of benign
ovarian tumour
2 227 Odds Ratio (Peto, Fixed, 95% CI) 0.10 [0.01, 0.77]
6 Short term recovery - pain (VAS) 1 127 Mean Difference (IV, Fixed, 95% CI) -1.0 [-1.55, -0.45]
6.1 Any type of benign
ovarian tumour
1 127 Mean Difference (IV, Fixed, 95% CI) -1.0 [-1.55, -0.45]
7 Short term recovery - pain (pain
free 24-48 hours post surgery)
1 127 Odds Ratio (Peto, Fixed, 95% CI) 9.64 [4.18, 22.19]
7.1 Any type of benign
ovarian tumour
1 127 Odds Ratio (Peto, Fixed, 95% CI) 9.64 [4.18, 22.19]
8 Short term recovery - pain
(requirement for analgesia)
Other data No numeric data
8.1 Any type of benign
ovarian tumour
Other data No numeric data
9 Length of hospital stay (days) 3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Any type of benign
ovarian tumour
3 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Laparoscopy versus laparotomy, Outcome 1 Surgery - Duration of surgery
(min).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 1 Surgery - Duration of surgery (min)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 48 71.5 (4.9) 50 42.6 (2.7) 28.90 [ 27.32, 30.48 ]
Buchweitz 2005 10 70 (17.5) 10 80.8 (30.7) -10.80 [ -32.70, 11.10 ]
Damiani 1998 34 74 (29) 34 83 (28) -9.00 [ -22.55, 4.55 ]
Mais 1995 20 70 (20) 20 67 (12) 3.00 [ -7.22, 13.22 ]
Yuen 1997 52 59.9 (0.9) 50 52.7 (1.9) 7.20 [ 6.62, 7.78 ]
2 Dermoid cysts
Mais 2003 20 85 (28) 20 73 (20) 12.00 [ -3.08, 27.08 ]
Morgante 1998 22 79.3 (26.6) 22 56.9 (14.5) 22.40 [ 9.74, 35.06 ]
Nitke 1996 20 93.6 (23.8) 18 55.6 (11.4) 38.00 [ 26.32, 49.68 ]
3 Ovarian endometriomata
Mais 1996 16 98 (36) 16 93 (28) 5.00 [ -17.35, 27.35 ]
-20 -10 0 10 20
favours laparoscopy favours laparotomy
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Analysis 1.2. Comparison 1 Laparoscopy versus laparotomy, Outcome 2 Surgery - Change of diagnosis to
malignant tumour.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 2 Surgery - Change of diagnosis to malignant tumour





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Buchweitz 2005 2/10 2/10 100.0 % 1.00 [ 0.12, 8.46 ]
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 116 114 100.0 % 1.00 [ 0.12, 8.46 ]
Total events: 2 (Laparoscopy), 2 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours laparoscopy Favours laparotomy
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Analysis 1.3. Comparison 1 Laparoscopy versus laparotomy, Outcome 3 Surgical Injury - Bladder.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 3 Surgical Injury - Bladder





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 1/50 100.0 % 0.13 [ 0.00, 6.56 ]
Subtotal (95% CI) 164 164 100.0 % 0.13 [ 0.00, 6.56 ]
Total events: 0 (Laparoscopy), 1 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours laparoscopy Favours laparotomy
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Analysis 1.4. Comparison 1 Laparoscopy versus laparotomy, Outcome 4 Surgical Injury - Ureter.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 4 Surgical Injury - Ureter





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/20 0/20 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 60 58 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
0.01 0.1 1 10 100
Favours laparoscopy Favours laparotomy
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Analysis 1.5. Comparison 1 Laparoscopy versus laparotomy, Outcome 5 Surgical Injury - Vascular.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 5 Surgical Injury - Vascular





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 1/48 0/50 50.0 % 7.70 [ 0.15, 388.55 ]
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 1/52 0/50 50.0 % 7.11 [ 0.14, 358.60 ]
Subtotal (95% CI) 164 164 100.0 % 7.40 [ 0.46, 118.39 ]
Total events: 2 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.42 (P = 0.16)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Laparoscopy versus laparotomy, Outcome 6 Surgical Injury - Small bowel.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 6 Surgical Injury - Small bowel





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.7. Comparison 1 Laparoscopy versus laparotomy, Outcome 7 Surgical Injury - Colon.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 7 Surgical Injury - Colon





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.8. Comparison 1 Laparoscopy versus laparotomy, Outcome 8 Post operative complications -
Blood transfusion required.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 8 Post operative complications - Blood transfusion required





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.9. Comparison 1 Laparoscopy versus laparotomy, Outcome 9 Post operative complications -
Haematoma.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 9 Post operative complications - Haematoma





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.10. Comparison 1 Laparoscopy versus laparotomy, Outcome 10 Post operative complications -
Febrile morbidity.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 10 Post operative complications - Febrile morbidity





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 5/48 12/50 45.3 % 0.39 [ 0.14, 1.11 ]
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 2/34 3/34 15.0 % 0.65 [ 0.11, 3.98 ]
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 3/52 10/50 36.5 % 0.28 [ 0.09, 0.90 ]
Subtotal (95% CI) 164 164 96.8 % 0.37 [ 0.18, 0.76 ]
Total events: 10 (Laparoscopy), 25 (Laparotomy)
Heterogeneity: Chi2 = 0.60, df = 2 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.71 (P = 0.0068)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 1/22 3.2 % 0.14 [ 0.00, 6.82 ]
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 3.2 % 0.14 [ 0.00, 6.82 ]
Total events: 0 (Laparoscopy), 1 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.00 (P = 0.32)
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 242 240 100.0 % 0.36 [ 0.18, 0.73 ]
Total events: 10 (Laparoscopy), 26 (Laparotomy)
Heterogeneity: Chi2 = 0.85, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 2.84 (P = 0.0045)
Test for subgroup differences: Chi2 = 0.25, df = 1 (P = 0.62), I2 =0.0%
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Analysis 1.11. Comparison 1 Laparoscopy versus laparotomy, Outcome 11 Post operative complications -
Incision infection.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 11 Post operative complications - Incision infection





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 1/48 5/50 85.1 % 0.26 [ 0.05, 1.32 ]
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 1/50 14.9 % 0.13 [ 0.00, 6.56 ]
Subtotal (95% CI) 164 164 100.0 % 0.23 [ 0.05, 1.05 ]
Total events: 1 (Laparoscopy), 6 (Laparotomy)
Heterogeneity: Chi2 = 0.10, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.058)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Laparoscopy versus laparotomy, Outcome 12 Post operative complications -
Urinary tract infection.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 12 Post operative complications - Urinary tract infection





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 2/50 23.1 % 0.14 [ 0.01, 2.24 ]
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 2/52 5/50 76.9 % 0.39 [ 0.08, 1.78 ]
Subtotal (95% CI) 164 164 100.0 % 0.30 [ 0.08, 1.16 ]
Total events: 2 (Laparoscopy), 7 (Laparotomy)
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.74 (P = 0.082)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Laparoscopy versus laparotomy, Outcome 13 Post operative complications -
Thromboembolism.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 13 Post operative complications - Thromboembolism





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 2/10 100.0 % 0.12 [ 0.01, 2.09 ]
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 100.0 % 0.12 [ 0.01, 2.09 ]
Total events: 0 (Laparoscopy), 2 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.45 (P = 0.15)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Laparoscopy versus laparotomy, Outcome 14 Blood loss by hemoglobin levels.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 14 Blood loss by hemoglobin levels





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Any type of benign ovarian tumour
Buchweitz 2005 10 1.4 (1.2) 10 1.7 (1.1) 100.0 % -0.30 [ -1.31, 0.71 ]
Subtotal (95% CI) 10 10 100.0 % -0.30 [ -1.31, 0.71 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
2 Dermoid cysts
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 10 10 100.0 % -0.30 [ -1.31, 0.71 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
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Analysis 1.15. Comparison 1 Laparoscopy versus laparotomy, Outcome 15 Perioperative mortality.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 15 Perioperative mortality





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.16. Comparison 1 Laparoscopy versus laparotomy, Outcome 16 Urinary retention.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 16 Urinary retention





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 4/50 100.0 % 0.12 [ 0.02, 0.89 ]
Subtotal (95% CI) 164 164 100.0 % 0.12 [ 0.02, 0.89 ]
Total events: 0 (Laparoscopy), 4 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.038)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Laparoscopy versus laparotomy, Outcome 17 Chemical peritonitis.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 17 Chemical peritonitis





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 0/22 Not estimable
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 1.18. Comparison 1 Laparoscopy versus laparotomy, Outcome 18 Intestinal obstruction.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 18 Intestinal obstruction





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 0/48 0/50 Not estimable
Buchweitz 2005 0/10 0/10 Not estimable
Damiani 1998 0/34 0/34 Not estimable
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 0/52 0/50 Not estimable
Subtotal (95% CI) 164 164 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 1/22 100.0 % 0.14 [ 0.00, 6.82 ]
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 100.0 % 0.14 [ 0.00, 6.82 ]
Total events: 0 (Laparoscopy), 1 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.00 (P = 0.32)
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Laparoscopy versus laparotomy, Outcome 19 1.18 Any adverse effect of
surgery (incl surgical injury or post surgery complication or other).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 19 1.18 Any adverse effect of surgery (incl surgical injury or post surgery complication or other)





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 12/48 23/50 43.6 % 0.40 [ 0.18, 0.92 ]
Buchweitz 2005 0/10 3/10 5.2 % 0.11 [ 0.01, 1.17 ]
Damiani 1998 2/34 3/34 9.0 % 0.65 [ 0.11, 3.98 ]
Mais 1995 0/20 0/20 Not estimable
Yuen 1997 6/52 21/50 38.5 % 0.21 [ 0.09, 0.51 ]
Subtotal (95% CI) 164 164 96.3 % 0.30 [ 0.18, 0.53 ]
Total events: 20 (Laparoscopy), 50 (Laparotomy)
Heterogeneity: Chi2 = 2.53, df = 3 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 4.21 (P = 0.000026)
2 Dermoid cysts
Mais 2003 0/20 0/20 Not estimable
Morgante 1998 0/22 2/22 3.7 % 0.13 [ 0.01, 2.13 ]
Nitke 1996 0/20 0/18 Not estimable
Subtotal (95% CI) 62 60 3.7 % 0.13 [ 0.01, 2.13 ]
Total events: 0 (Laparoscopy), 2 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 242 240 100.0 % 0.29 [ 0.17, 0.51 ]
Total events: 20 (Laparoscopy), 52 (Laparotomy)
Heterogeneity: Chi2 = 2.88, df = 4 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 4.41 (P = 0.000010)
Test for subgroup differences: Chi2 = 0.35, df = 1 (P = 0.56), I2 =0.0%
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Analysis 1.20. Comparison 1 Laparoscopy versus laparotomy, Outcome 20 Short term recovery - pain
(VAS).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 20 Short term recovery - pain (VAS)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Any type of benign ovarian tumour
Mais 1995 20 2 (1.34) 20 4.7 (1.79) 11.8 % -2.70 [ -3.68, -1.72 ]
Yuen 1997 52 3.1 (2.5) 50 4.9 (2.5) 12.0 % -1.80 [ -2.77, -0.83 ]
Subtotal (95% CI) 72 70 23.8 % -2.25 [ -2.94, -1.56 ]
Heterogeneity: Chi2 = 1.64, df = 1 (P = 0.20); I2 =39%
Test for overall effect: Z = 6.38 (P < 0.00001)
2 Dermoid cysts
Morgante 1998 22 1.4 (0.6) 22 3.8 (0.7) 76.2 % -2.40 [ -2.79, -2.01 ]
Subtotal (95% CI) 22 22 76.2 % -2.40 [ -2.79, -2.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 12.21 (P < 0.00001)
Total (95% CI) 94 92 100.0 % -2.36 [ -2.70, -2.03 ]
Heterogeneity: Chi2 = 1.78, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 13.77 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.15, df = 1 (P = 0.70), I2 =0.0%
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Analysis 1.21. Comparison 1 Laparoscopy versus laparotomy, Outcome 21 Short term recovery - pain
(painfree 24-48 hours post surgery).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 21 Short term recovery - pain (painfree 24-48 hours post surgery)





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 26/48 7/50 25.8 % 5.93 [ 2.58, 13.65 ]
Mais 1995 16/20 3/20 11.9 % 12.70 [ 3.73, 43.25 ]
Yuen 1997 28/52 10/50 28.1 % 4.19 [ 1.89, 9.33 ]
Subtotal (95% CI) 120 120 65.8 % 5.87 [ 3.48, 9.90 ]
Total events: 70 (Laparoscopy), 20 (Laparotomy)
Heterogeneity: Chi2 = 2.20, df = 2 (P = 0.33); I2 =9%
Test for overall effect: Z = 6.65 (P < 0.00001)
2 Dermoid cysts
Mais 2003 16/20 3/20 11.9 % 12.70 [ 3.73, 43.25 ]
Morgante 1998 15/22 3/22 12.7 % 9.07 [ 2.76, 29.76 ]
Subtotal (95% CI) 42 42 24.6 % 10.68 [ 4.55, 25.06 ]
Total events: 31 (Laparoscopy), 6 (Laparotomy)
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 5.44 (P < 0.00001)
3 Ovarian endometriomata
Mais 1996 14/16 3/16 9.6 % 14.51 [ 3.70, 56.90 ]
Subtotal (95% CI) 16 16 9.6 % 14.51 [ 3.70, 56.90 ]
Total events: 14 (Laparoscopy), 3 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 3.84 (P = 0.00013)
Total (95% CI) 178 178 100.0 % 7.42 [ 4.86, 11.33 ]
Total events: 115 (Laparoscopy), 29 (Laparotomy)
Heterogeneity: Chi2 = 4.75, df = 5 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 9.28 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.39, df = 2 (P = 0.30), I2 =16%
0.001 0.01 0.1 1 10 100 1000
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Analysis 1.22. Comparison 1 Laparoscopy versus laparotomy, Outcome 22 Short term recovery - Pain
(requirement for analgesia).
Short term recovery - Pain (requirement for analgesia)
Study Drug mean (SD) laparoscop mean (SD) laparot difference
any type of benign ovarian tumour
Badawy 2002 Diclofenac sodium 75 mg 2.9 (1.2) doses 4.6 (3.9) doses p=0.003, significant difference be-
tween the two groups
Badawy 2002
Buchweitz 2005 Piritramine 3.8 (1.2) doses 4.4 (1.5) doses
Buchweitz 2005
Yuen 1997 Dologesic 1.1 (0.9) doses 1.3 (0.9) doses NS
Yuen 1997 Morphine 0.5 (0.8) doses 0.8 (0.8) doses NS
Analysis 1.23. Comparison 1 Laparoscopy versus laparotomy, Outcome 23 Recurrence at 6-12 months.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 23 Recurrence at 6-12 months





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Damiani 1998 1/34 1/34 100.0 % 1.00 [ 0.06, 16.33 ]
Mais 1995 0/20 0/20 Not estimable
Subtotal (95% CI) 54 54 100.0 % 1.00 [ 0.06, 16.33 ]
Total events: 1 (Laparoscopy), 1 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Dermoid cysts
Mais 2003 0/15 0/16 Not estimable
0.001 0.01 0.1 1 10 100 1000
Favours laparoscopy Favours laparotomy
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(. . . Continued)





n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Subtotal (95% CI) 15 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Mais 1996 0/16 0/16 Not estimable
Subtotal (95% CI) 16 16 Not estimable
Total events: 0 (Laparoscopy), 0 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 85 86 100.0 % 1.00 [ 0.06, 16.33 ]
Total events: 1 (Laparoscopy), 1 (Laparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours laparoscopy Favours laparotomy
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Analysis 1.24. Comparison 1 Laparoscopy versus laparotomy, Outcome 24 Length of hospital stay (days).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 24 Length of hospital stay (days)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Any type of benign ovarian tumour
Badawy 2002 48 0.75 (0.25) 50 3.75 (1.25) 19.1 % -3.00 [ -3.35, -2.65 ]
Buchweitz 2005 10 6.1 (1.2) 10 10 (1.6) 3.0 % -3.90 [ -5.14, -2.66 ]
Damiani 1998 34 1.6 (0.8) 34 4.8 (1.4) 11.6 % -3.20 [ -3.74, -2.66 ]
Mais 1995 20 2 (0.7) 20 4.6 (1) 11.8 % -2.60 [ -3.13, -2.07 ]
Yuen 1997 52 2.6 (1.7) 50 4.9 (2.2) 6.9 % -2.30 [ -3.07, -1.53 ]
Subtotal (95% CI) 164 164 52.3 % -2.91 [ -3.28, -2.55 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 7.52, df = 4 (P = 0.11); I2 =47%
Test for overall effect: Z = 15.63 (P < 0.00001)
2 Dermoid cysts
Morgante 1998 22 3.18 (0.39) 22 6.32 (1.09) 13.5 % -3.14 [ -3.62, -2.66 ]
Nitke 1996 20 0.93 (0.28) 18 3.8 (0.48) 24.9 % -2.87 [ -3.12, -2.62 ]
Subtotal (95% CI) 42 40 38.3 % -2.93 [ -3.15, -2.70 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 25.56 (P < 0.00001)
3 Ovarian endometriomata
Mais 1996 16 2.25 (0.93) 16 4.63 (0.89) 9.3 % -2.38 [ -3.01, -1.75 ]
Subtotal (95% CI) 16 16 9.3 % -2.38 [ -3.01, -1.75 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.40 (P < 0.00001)
Total (95% CI) 222 220 100.0 % -2.88 [ -3.11, -2.66 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 11.15, df = 7 (P = 0.13); I2 =37%
Test for overall effect: Z = 25.33 (P < 0.00001)
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Analysis 1.25. Comparison 1 Laparoscopy versus laparotomy, Outcome 25 Economic outcomes - total cost
(US$1000 1993).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 1 Laparoscopy versus laparotomy
Outcome: 25 Economic outcomes - total cost (US$1000 1993)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Any type of benign ovarian tumour
Damiani 1998 34 3191 (513) 34 4236 (741) 100.0 % -1045.00 [ -1347.94, -742.06 ]
Subtotal (95% CI) 34 34 100.0 % -1045.00 [ -1347.94, -742.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.76 (P < 0.00001)
2 Dermoid cysts
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Ovarian endometriomata
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 1 Surgery - duration of surgery.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 1 Surgery - duration of surgery





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Fanfani 2004 50 87 (44.8) 50 71.9 (31.2) 15.10 [ -0.03, 30.23 ]
Panici 2007 30 81 (18.8) 30 47 (12.4) 34.00 [ 25.94, 42.06 ]
Panici 2007a 63 45 (11.9) 64 35 (11.8) 10.00 [ 5.88, 14.12 ]
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Analysis 2.2. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 2 Surgery - change of diagnosis
to malignant tumour.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 2 Surgery - change of diagnosis to malignant tumour
Study or subgroup Laparoscopy Minilaparotomy Odds Ratio Weight Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Fanfani 2004 2/50 1/50 63.9 % 2.04 [ 0.18, 23.27 ]
Panici 2007 1/30 0/30 36.1 % 3.10 [ 0.12, 79.23 ]
Total (95% CI) 80 80 100.0 % 2.37 [ 0.34, 16.61 ]
Total events: 3 (Laparoscopy), 1 (Minilaparotomy)
Heterogeneity: Chi2 = 0.04, df = 1 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.3. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 3 Post operative complications -
Febrile morbidity.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 3 Post operative complications - Febrile morbidity
Study or subgroup Laparoscopy Minilaparotomy Odds Ratio Weight Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Fanfani 2004 0/50 2/50 48.7 % 0.19 [ 0.01, 4.10 ]
Panici 2007a 0/63 3/64 51.3 % 0.14 [ 0.01, 2.73 ]
Total (95% CI) 113 114 100.0 % 0.16 [ 0.02, 1.38 ]
Total events: 0 (Laparoscopy), 5 (Minilaparotomy)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours laparoscopy Favours minilaparotomy
Analysis 2.4. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 4 Post operative complications -
Incison infection.
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 4 Post operative complications - Incison infection
Study or subgroup Laparoscopy Minilaparotomy Odds Ratio Weight Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Panici 2007a 0/63 3/64 100.0 % 0.14 [ 0.01, 2.73 ]
Total (95% CI) 63 64 100.0 % 0.14 [ 0.01, 2.73 ]
Total events: 0 (Laparoscopy), 3 (Minilaparotomy)
Heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
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Analysis 2.5. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 5 Any adverse effect of surgery
(incl surgical injury or post surgery complication or other).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 5 Any adverse effect of surgery (incl surgical injury or post surgery complication or other)
Study or subgroup Laparoscopy Minilaparotomy Odds Ratio Weight Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Fanfani 2004 0/50 3/50 48.5 % 0.13 [ 0.01, 2.67 ]
Panici 2007a 0/63 6/64 51.5 % 0.07 [ 0.00, 1.29 ]
Total (95% CI) 113 114 100.0 % 0.10 [ 0.01, 0.77 ]
Total events: 0 (Laparoscopy), 9 (Minilaparotomy)
Heterogeneity: Chi2 = 0.09, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 2.20 (P = 0.028)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 6 Short term recovery - pain
(VAS).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 6 Short term recovery - pain (VAS)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Any type of benign ovarian tumour
Panici 2007a 63 3 (1) 64 4 (2) 100.0 % -1.00 [ -1.55, -0.45 ]
Total (95% CI) 63 64 100.0 % -1.00 [ -1.55, -0.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.57 (P = 0.00035)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 7 Short term recovery - pain
(pain free 24-48 hours post surgery).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 7 Short term recovery - pain (pain free 24-48 hours post surgery)
Study or subgroup Minilaparotomy Laparoscopy Odds Ratio Weight Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Any type of benign ovarian tumour
Panici 2007a 53/64 21/63 100.0 % 9.64 [ 4.18, 22.19 ]
Total (95% CI) 64 63 100.0 % 9.64 [ 4.18, 22.19 ]
Total events: 53 (Minilaparotomy), 21 (Laparoscopy)
Heterogeneity: not applicable
Test for overall effect: Z = 5.32 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours minilaparotomy Favours laparoscopy
Analysis 2.8. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 8 Short term recovery - pain
(requirement for analgesia).
Short term recovery - pain (requirement for analgesia)
Study Drug mean (SD) laparoscopy mean (SD) laparotomy difference
Any type of benign ovarian tumour
Fanfani 2004 morphine chloridate/
ketoralac
1.3 (0.5) doses 1.2 (0.6) doses NS
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Analysis 2.9. Comparison 2 Laparoscopy versus minilaparotomy, Outcome 9 Length of hospital stay (days).
Review: Laparoscopy versus laparotomy for benign ovarian tumour
Comparison: 2 Laparoscopy versus minilaparotomy
Outcome: 9 Length of hospital stay (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Any type of benign ovarian tumour
Fanfani 2004 50 2 (0.8) 50 2.2 (0.6) -0.20 [ -0.48, 0.08 ]
Panici 2007 30 1 (0.47) 30 1 (0.95) 0.0 [ -0.38, 0.38 ]
Panici 2007a 63 1 (0.59) 64 2 (0.47) -1.00 [ -1.19, -0.81 ]
-10 -5 0 5 10
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A P P E N D I C E S
Appendix 1. MEDLINE
MEDLINE was searched using the following strategy:
1. Randomized controlled trial. pt.
2. Controlled clinical trial. pt.
3. Randomised controlled trials/
4. random allocation/
5. double -blind method/
6. single-blind method/
7. or/1-6
8. clinical trial. pt
9. Exp clinical trials/
10. (clin$ adj25 trial$).ti,ab,sh.






17. animal/ not (human/ and animal/)
18. 7 or 16
19.18 not 17
20. Exp Ovarian Cysts/
21. Exp ENDOMETRIOSIS/
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30. exp Surgical procedures, Operative/
31.or/26-30
32. 25 and 31



















13 exp clinical trials/
14.clinical trial.pt
15. Clinical trial.pt
16. (clinic$ adj trial$).tw
17.((singl$ or doubl$ or trebl$ or trip$) adj (blind$3 or mask$3)).tw.






24. 11 AND 23
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Appendix 3. EMBASE
EMBASE was searched using the following strategy:
1. Controlled study/or Randomized Controlled trial/
2. double blind procedure/









12.((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).ti,ab,hw,tn,mf.
13. (comparative adj5 trial$).ti,ab,hw,tn,mf.
14. (clinical adj5 trial$).ti,ab,hw,tn,mf.
15. or/ 1-14
16. nonhuman/
17. animal/ not (human/and animal/)
18. or/16-17
19. 15 not 18
20. exp Ovary Cyst/
21. exp ENDOMETRIOSIS/
22. (ovar$ adj5 tumor?r).tw.
23. exp Adnexa Disease/






30. exp Surgical Technique/
31. or/26-30
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10.surg$.tw.
11 or/1-10






18. 11 and 17
W H A T ’ S N E W
Last assessed as up-to-date: 9 November 2007.
Date Event Description
20 September 2010 Amended Contact details updated.
H I S T O R Y
Protocol first published: Issue 2, 2004
Review first published: Issue 3, 2005
Date Event Description
11 February 2009 New citation required but conclusions have not
changed
Review updated October 2008
27 October 2008 New search has been performed This review was updated in October 2008 and six ad-
ditional studies were included
15 April 2008 Amended Converted to new review format.
10 November 2007 New citation required and conclusions have changed Substantive amendment
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